[
  {
    "start": "0",
    "end": "6000"
  },
  {
    "text": "Today, I will talk about graph neural networks in computational biology. And, um, there has been, um,",
    "start": "4070",
    "end": "11235"
  },
  {
    "start": "6000",
    "end": "59000"
  },
  {
    "text": "a tremendous surge in- of interest in leveraging, ah, graph neural networks and graph representation learning,",
    "start": "11235",
    "end": "17280"
  },
  {
    "text": "in particular, ah, for learning meaningful representations of biology and meaningful representations of datasets and",
    "start": "17280",
    "end": "24000"
  },
  {
    "text": "entities when co- we encounter in biology and medicine. And so over the last few years, we have seen, ah,",
    "start": "24000",
    "end": "30170"
  },
  {
    "text": "several prominent examples where GNNs have been used successfully, ah, to learn, uh, representations that have enabled critical predictions in a variety of downstream tasks,",
    "start": "30170",
    "end": "39635"
  },
  {
    "text": "including predictions about discovering novel interactions about- between proteins, information about, ah, uh, treat- uh,",
    "start": "39635",
    "end": "46760"
  },
  {
    "text": "succes- potentially successful disease treatments, um, opportunities about, uh, novel- regarding novel drugs and so on.",
    "start": "46760",
    "end": "55295"
  },
  {
    "text": "And so that has, um- that of course, is- is very interesting and particularly, um,",
    "start": "55295",
    "end": "62240"
  },
  {
    "start": "59000",
    "end": "165000"
  },
  {
    "text": "a natural question to ask is, why do we see that graph neural networks,",
    "start": "62240",
    "end": "67859"
  },
  {
    "text": "achieve such success in biomedical and biological data? And so to answer this question,",
    "start": "67860",
    "end": "74200"
  },
  {
    "text": "we need to think a bit about, um, [NOISE] biology and- and observe that biology is actually highly interconnected to the- uh,",
    "start": "74200",
    "end": "81610"
  },
  {
    "text": "in- in the sense that, um, the way drugs work when- when people take",
    "start": "81610",
    "end": "86700"
  },
  {
    "text": "them is not that they work independently of each other, but the way drugs work is they actually affect certain number o- of molecules, ah,",
    "start": "86700",
    "end": "94405"
  },
  {
    "text": "in humans cells that are typically proteins, and those proteins interact with each other and",
    "start": "94405",
    "end": "100030"
  },
  {
    "text": "then- then these effects are then propagated. The way they are propagating in- in human body and in",
    "start": "100030",
    "end": "106130"
  },
  {
    "text": "human cells is through those underlying biological networks. So we can really see that biology is interconnected at various different scales,",
    "start": "106130",
    "end": "114799"
  },
  {
    "text": "from the scale of genomic sequences where we see interactions between parts of the genome,",
    "start": "114799",
    "end": "121190"
  },
  {
    "text": "to the scale of interactions between proteins and molecules in- within a cell,",
    "start": "121190",
    "end": "126260"
  },
  {
    "text": "to- to interactions of external agents that are included in the human body, such as drugs and therapeutics,",
    "start": "126260",
    "end": "132600"
  },
  {
    "text": "[NOISE] all the way to the scale of populations or entire ecosystems where we have,",
    "start": "132600",
    "end": "138215"
  },
  {
    "text": "for example, health care systems and dependencies between different institutions, different hospitals, or different kinds of",
    "start": "138215",
    "end": "144409"
  },
  {
    "text": "symptoms within a heal- within healthcare records. So the effects of many of biological then interventions,",
    "start": "144410",
    "end": "152090"
  },
  {
    "text": "many of biological, um, e- entities are- they're really network effects. And because of that, it makes lots of sense to study the biology through the lens",
    "start": "152090",
    "end": "160460"
  },
  {
    "text": "of networks and interactions between biologically relevant entities. So to unpack this a bit,",
    "start": "160460",
    "end": "167150"
  },
  {
    "start": "165000",
    "end": "335000"
  },
  {
    "text": "we can try to understand why are networks in biology so powerful? And I'll look- I'll look- I will take a particular example to- to explain that.",
    "start": "167150",
    "end": "175175"
  },
  {
    "text": "So let's look for a- let's take a look at the human protein interaction network. This is a network where nodes,",
    "start": "175175",
    "end": "181500"
  },
  {
    "text": "um, represent human proteins, and two proteins are connected by an edge if,",
    "start": "181500",
    "end": "186815"
  },
  {
    "text": "um, the proteins physically interact. Meaning that at some point in time the two proteins are physically close in the cell,",
    "start": "186815",
    "end": "194000"
  },
  {
    "text": "and, um, you might want to know, well, why- why are then proteins interacting with each other?",
    "start": "194000",
    "end": "200885"
  },
  {
    "text": "Um, if we look at a particular sub-region of protein interaction network, which might be this particular subgraph on- o- on five human proteins where we see, ah,",
    "start": "200885",
    "end": "210485"
  },
  {
    "text": "five interactions, is there any significance between these two protein MXS1 and B9D2 so- that they- in,",
    "start": "210485",
    "end": "218690"
  },
  {
    "text": "uh- in- in the sense that, what does it mean and what are implications of them interacting with each other?",
    "start": "218690",
    "end": "223920"
  },
  {
    "text": "And to answer this question, what we can do is to overlay on that, um, protein interaction network",
    "start": "223920",
    "end": "230525"
  },
  {
    "text": "information about what are diseases that those proteins are involved in. And if we do that for this particular example,",
    "start": "230525",
    "end": "236945"
  },
  {
    "text": "we can see that the these three proteins that are highlighted here in red are all associated with the disease- with the same disease.",
    "start": "236945",
    "end": "243950"
  },
  {
    "text": "Meaning that when there are certain alterations in those two proteins, a particular disease would develop.",
    "start": "243950",
    "end": "249635"
  },
  {
    "text": "And so what is interesting to- to- to explore and obs- and observe is that if we overlay, um,",
    "start": "249635",
    "end": "257750"
  },
  {
    "text": "information about involvement of proteins in various diseases onto this- uh, onto protein interaction network,",
    "start": "257750",
    "end": "263975"
  },
  {
    "text": "we can see that proteins associated with the same disease tend to agglomerate or cluster in certain regions,",
    "start": "263975",
    "end": "270515"
  },
  {
    "text": "in certain neighborhoods of the network. And that has, over the last two decades, yield to very powerful paradigms in, um,",
    "start": "270515",
    "end": "278585"
  },
  {
    "text": "biology and medicine because it's powerful as it allows us to identify new proteins that might be involved in",
    "start": "278585",
    "end": "285590"
  },
  {
    "text": "disease by simply exploring the surrounding and lo- n- network neighborhoods of those proteins",
    "start": "285590",
    "end": "291770"
  },
  {
    "text": "that were already known to be associated with the disease. That particular longstanding paradigm is known as local hypothesis.",
    "start": "291770",
    "end": "300380"
  },
  {
    "text": "And in other words, it means that proteins involved in the same disease, proteins that when mutated are,",
    "start": "300380",
    "end": "307930"
  },
  {
    "text": "um, lead to the same disease, they- they have an increasing tendency to interact with each other,",
    "start": "307930",
    "end": "313789"
  },
  {
    "text": "meaning that they would be connected in our PPI network. So the implication of that local hypothesis is that, ah,",
    "start": "313790",
    "end": "320820"
  },
  {
    "text": "m- mutations in interacting proteins often lead to similar diseases. And now that we know that,",
    "start": "320820",
    "end": "327020"
  },
  {
    "text": "we can effectively leverage that information as inf- uh, as prior information for- for our- for our machine learning models.",
    "start": "327020",
    "end": "334865"
  },
  {
    "text": "While I'll explain this particular local hypothesis in the case of human protein interaction networks and diseases,",
    "start": "334865",
    "end": "341794"
  },
  {
    "start": "335000",
    "end": "403000"
  },
  {
    "text": "similar findings apply to a broad range of different kinds of networks that we can see in biology.",
    "start": "341795",
    "end": "348440"
  },
  {
    "text": "Going from protein interaction networks to networks where nodes are patients related and connected based on",
    "start": "348440",
    "end": "354919"
  },
  {
    "text": "familial or- relationships or similarity of the genomic profiles, to networks representing hierarchies of several systems,",
    "start": "354920",
    "end": "362419"
  },
  {
    "text": "networks representing disease pathways, um, gene interaction networks, cell-cell similarity networks, and many others.",
    "start": "362419",
    "end": "370090"
  },
  {
    "text": "And so that, um, notion of local hypothesis where we see that, um,",
    "start": "370090",
    "end": "375439"
  },
  {
    "text": "entities with similar properties all- all tend to cluster and agglomerate in certain network regions, um,",
    "start": "375440",
    "end": "384060"
  },
  {
    "text": "are- is really one of the core observations and motivation and guiding principle that can explain why",
    "start": "384060",
    "end": "391220"
  },
  {
    "text": "graph neural networks are so well suited for the analysis of biological networks and why they have already led to several very successful,",
    "start": "391220",
    "end": "399199"
  },
  {
    "text": "uh, applications to biomedical problems. So- so that's all great and fantastic vision that we can share.",
    "start": "399200",
    "end": "408110"
  },
  {
    "start": "403000",
    "end": "512000"
  },
  {
    "text": "It's a nice motivation for great- for why it makes sense to use graph neural networks for biological data.",
    "start": "408110",
    "end": "413220"
  },
  {
    "text": "But biological networks also present some fundamental challenges that we can solve through algorithmic innovation.",
    "start": "413220",
    "end": "419900"
  },
  {
    "text": "So there are a number of challenges, I will just mention tree here. Um, so the first challenge is that biological networks tend to involve heterogeneous interactions",
    "start": "419900",
    "end": "428450"
  },
  {
    "text": "that span from the mo- molecular level all the way to the level of whole populations or societies.",
    "start": "428450",
    "end": "434720"
  },
  {
    "text": "And so typically [NOISE] the challenge is how to computationally operationalize the data. What- how to even construct then- the graphs",
    "start": "434720",
    "end": "442100"
  },
  {
    "text": "that are then amenable to- to machine learning. The second challenge is that,",
    "start": "442100",
    "end": "447410"
  },
  {
    "text": "um, networks in biology, uh, contain data that you are co- that come from a variety of different resources,",
    "start": "447410",
    "end": "454024"
  },
  {
    "text": "including experimental readouts, curated annotations, and metadata. And we really need to consider all those data",
    "start": "454024",
    "end": "461210"
  },
  {
    "text": "jointly because no single datatype can really capture all the fact- factors that are necessary to",
    "start": "461210",
    "end": "467900"
  },
  {
    "text": "understand a particular complex phenomenon such as a disease. It really is, um,",
    "start": "467900",
    "end": "473185"
  },
  {
    "text": "that we wo- need to, uh, co- co- jointly consider the data from diverse resources to do so.",
    "start": "473185",
    "end": "479389"
  },
  {
    "text": "And finally, biological networks are by definition noisy and there by definition are incomplete because our understanding",
    "start": "479390",
    "end": "486170"
  },
  {
    "text": "of the nature and biology is incomplete. And they are noisy because inherent natural variations as well as",
    "start": "486170",
    "end": "491900"
  },
  {
    "text": "limitations of current biotechnological platforms that generate the data, which means that we need to operate with the assumption that our data will be missing,",
    "start": "491900",
    "end": "501425"
  },
  {
    "text": "it will contain po- repeated measurements, even contradictory observations that can plague the analysis,",
    "start": "501425",
    "end": "507530"
  },
  {
    "text": "and methods need to be robust against [NOISE] these issues. So the plan for today lecture is the following,",
    "start": "507530",
    "end": "514360"
  },
  {
    "start": "512000",
    "end": "570000"
  },
  {
    "text": "um, I will [NOISE], uh, talk about three vignettes that will highlight some of these challenge- some of the challenges, uh,",
    "start": "514360",
    "end": "521419"
  },
  {
    "text": "for- for wor- dealing with biological networks as well as propose solutions and show examples of",
    "start": "521420",
    "end": "526879"
  },
  {
    "text": "successful applications of graph neural networks in computational biology. So the part that I will touch are- are the que- first",
    "start": "526880",
    "end": "534079"
  },
  {
    "text": "will be the question related to modeling safety of drugs and, um, safety of combinations of drugs.",
    "start": "534080",
    "end": "539899"
  },
  {
    "text": "Second, I will talk about predicting patient outcomes and disease classification. And finally, we will,",
    "start": "539900",
    "end": "545810"
  },
  {
    "text": "ah, discuss, um, um, m- methods for identifying effective disease treatments and for",
    "start": "545810",
    "end": "551840"
  },
  {
    "text": "identifying promising therapeutic opportunities for emerging diseases. And along the way, I will also highlight some of new- uh,",
    "start": "551840",
    "end": "558935"
  },
  {
    "text": "technical work that was motivated by- by- by these specific biomedical problems. So let's start with the first topic, which is that of,",
    "start": "558935",
    "end": "566480"
  },
  {
    "text": "ah, [NOISE] modern drug safety and modeling drug combinations. So this work is really motivated by the problem that is known as polytherapy,",
    "start": "566480",
    "end": "575070"
  },
  {
    "start": "570000",
    "end": "711000"
  },
  {
    "text": "sometimes also called polypharmacy. It refers to the situation where patients take multiple drugs at the same time to treat complex or coexisting disease.",
    "start": "575070",
    "end": "583895"
  },
  {
    "text": "This is a problem that is very common, actually. 46% of people over 65 years take",
    "start": "583895",
    "end": "590149"
  },
  {
    "text": "more than five drugs that are prescribed to them by the do- their doctor at the same time. It's not uncommon to encounter patients that",
    "start": "590150",
    "end": "597290"
  },
  {
    "text": "take more than 20 drugs to treat heart diseases, de- depression, cancer, some other complex disease.",
    "start": "597290",
    "end": "602730"
  },
  {
    "text": "So the problem with that is that when a patient takes m- several drugs at the same time,",
    "start": "602730",
    "end": "607910"
  },
  {
    "text": "they're at much higher risk for developing adverse events. And there are estimates that",
    "start": "607910",
    "end": "613550"
  },
  {
    "text": "fi- around 50% of- 15% of the US population is affected by those unwanted side effects,",
    "start": "613550",
    "end": "618750"
  },
  {
    "text": "and that represents a huge burden both for individuals as well as for the entire health care system in terms of rising health care costs.",
    "start": "618750",
    "end": "627040"
  },
  {
    "text": "So when I said that individuals are at higher risk of developing adverse- unintended adverse events,",
    "start": "627040",
    "end": "633325"
  },
  {
    "text": "what did I actually mean by that? So when patients take m- multiple drugs at the same time,",
    "start": "633325",
    "end": "639820"
  },
  {
    "text": "because we now know that drugs don't act independently of each other, they might give rise to unexpected interactions between drugs.",
    "start": "639820",
    "end": "647695"
  },
  {
    "text": "So what does that mean? Let's look at this hypothetical scenario where we have a system with just two drugs.",
    "start": "647695",
    "end": "652810"
  },
  {
    "text": "We have a blue pill and a red pill. So when a patient takes blue pill alone, um,",
    "start": "652810",
    "end": "658280"
  },
  {
    "text": "there are no side effects observed and the desired therapeutic effect- e- effect is achieved and everything is- is- is well.",
    "start": "658280",
    "end": "665275"
  },
  {
    "text": "When a patient takes red pill alone, no side effects are observed and everything is okay. However, when a patient takes blue and red pill together,",
    "start": "665275",
    "end": "672890"
  },
  {
    "text": "then with certain probability, the patient would experience side effects, um, uh, when taking that combination of drug.",
    "start": "672890",
    "end": "680279"
  },
  {
    "text": "So that is surprising and unexpected because if the two drugs would act completely independently of each other,",
    "start": "680280",
    "end": "686300"
  },
  {
    "text": "then you would not expect to see any significant side effects when the two drugs are taken together.",
    "start": "686300",
    "end": "692480"
  },
  {
    "text": "So our learning task for- for- for this part of the talk, we will- we- uh, we- is the following.",
    "start": "692480",
    "end": "698329"
  },
  {
    "text": "We want to design a model that will be able to predict how likely a particular combination of drugs lead to a particular side effect.",
    "start": "698330",
    "end": "706250"
  },
  {
    "text": "So that is the- uh, the- the- the test that you want to solve. Okay, so na- natural question to ask is,",
    "start": "706250",
    "end": "713660"
  },
  {
    "start": "711000",
    "end": "829000"
  },
  {
    "text": "now that we know what is our question, is modeling drug combinations and modern drug interactions really a challenging problem?",
    "start": "713660",
    "end": "720529"
  },
  {
    "text": "As I answer to that is yes, it's a very challenging problem. Why is it so challenging? First, and that's perhaps the core challenge,",
    "start": "720530",
    "end": "727714"
  },
  {
    "text": "is that we can see a combinatorial explosion of possible combinations of drugs. Even if you take only a set of drugs that are approved in",
    "start": "727715",
    "end": "735140"
  },
  {
    "text": "the US and we consider only combinations that consists of two drugs, there are over 30 million possible combinations of two drugs.",
    "start": "735140",
    "end": "742010"
  },
  {
    "text": "There are over 20 billion possible combinations of three drugs and many more higher other drug interactions.",
    "start": "742010",
    "end": "747905"
  },
  {
    "text": "So the implication of that is- that is- is certainly infeasible in po- in- to test,",
    "start": "747905",
    "end": "753410"
  },
  {
    "text": "er, safety of those combinations of drugs in the lab, which effectively means that these drugs that are approved by- uh,",
    "start": "753410",
    "end": "760970"
  },
  {
    "text": "by FDA and other regulatory agencies, they get to the market, and then patients take them,",
    "start": "760970",
    "end": "766145"
  },
  {
    "text": "and then we see what happens. All right. So this is a huge opportunity for computational models to, ah, prioritize,",
    "start": "766145",
    "end": "772040"
  },
  {
    "text": "and a priori identify, and flag those combinations of drugs that might be unsafe before they are really used in real patients.",
    "start": "772040",
    "end": "778775"
  },
  {
    "text": "The second problem is that, ah, dr- er, un- unexpected drug interactions are by definition, non-linear, non-additive effect.",
    "start": "778775",
    "end": "787220"
  },
  {
    "text": "Right? An interaction is defined as an effect that is different from what wou- is an additive effect of individual drugs,",
    "start": "787220",
    "end": "795140"
  },
  {
    "text": "which presents its own set of challenges. And finally, you might think of this problem as a kind of big data problem because we'll be working",
    "start": "795140",
    "end": "802850"
  },
  {
    "text": "with the set of all drugs in the US and all adverse events associated with those drugs,",
    "start": "802850",
    "end": "808550"
  },
  {
    "text": "and there will be millions of those adverse event reports. But very quickly, we get down to the small data problem.",
    "start": "808550",
    "end": "814700"
  },
  {
    "text": "Where actually for any particular combination of drug there is just a small subset of patients that take that combination of drugs and,",
    "start": "814700",
    "end": "821524"
  },
  {
    "text": "um, there might be actually no information available about those combinations that are not yet used in patients.",
    "start": "821525",
    "end": "827315"
  },
  {
    "text": "And so that's another challenge. So to tackle this particular challenge,",
    "start": "827315",
    "end": "832430"
  },
  {
    "start": "829000",
    "end": "913000"
  },
  {
    "text": "what I will mention is an approach that is called decagon, that uses- that use graph neural networks to predict safety of combinations of drugs.",
    "start": "832430",
    "end": "840920"
  },
  {
    "text": "So decagon was defined on a polypharmacy knowledge graph that had the following structure.",
    "start": "840920",
    "end": "846305"
  },
  {
    "text": "It's a graph with, ah, two kinds of entities, drugs and proteins. So in this particular, uh, case, um,",
    "start": "846305",
    "end": "852875"
  },
  {
    "text": "drugs are represented by green triangles, an edge between two drugs has a particular type.",
    "start": "852875",
    "end": "858620"
  },
  {
    "text": "So an edge of type r_1 between two drugs would indicate that a specific type of interaction,",
    "start": "858620",
    "end": "864800"
  },
  {
    "text": "a specific adverse event, r_1 is observed when- uh, in patients that take the two, um, um,",
    "start": "864800",
    "end": "872150"
  },
  {
    "text": "drugs, ah, together and their side effects cannot be clearly attributed to either drug alone in that part.",
    "start": "872150",
    "end": "878405"
  },
  {
    "text": "Of course, in addition to knowing- um, um, include information about existing interactions between drugs,",
    "start": "878405",
    "end": "884690"
  },
  {
    "text": "we want to understand how those drugs actually work in terms of ha- what part of the body they affect,",
    "start": "884690",
    "end": "891260"
  },
  {
    "text": "and how the- they change activity of human cells. And so for that, the second mode information in",
    "start": "891260",
    "end": "897590"
  },
  {
    "text": "the knowledge graph connects drugs to their protein targets. And that, uh, proteins are represented by, ah, orange circles.",
    "start": "897590",
    "end": "905330"
  },
  {
    "text": "And then we know that proteins, ah, interact with each other, which gives rise to this underlying protein-protein interaction network.",
    "start": "905330",
    "end": "912875"
  },
  {
    "text": "So given this, ah, um, multimodal, ah,",
    "start": "912875",
    "end": "918140"
  },
  {
    "start": "913000",
    "end": "1022000"
  },
  {
    "text": "polypharmacy network, the project I would describe it is called Decagon, ah, has, er, two components.",
    "start": "918140",
    "end": "924440"
  },
  {
    "text": "And so in the first component, in the encoder phase, it will take the multimodal network, it will learn an embedding, ah,",
    "start": "924440",
    "end": "930725"
  },
  {
    "text": "for every drug, and every protein out in that, um, graph, and then it will average those embeddings to predict labeled edges between",
    "start": "930725",
    "end": "940010"
  },
  {
    "text": "drug nodes that would correspond to predict its drug interactions or adverse events of combinations of drugs.",
    "start": "940010",
    "end": "946130"
  },
  {
    "text": "So let's just, uh, briefly take a look at, ah, that. Um, so the key idea for generating embeddings of",
    "start": "946130",
    "end": "953750"
  },
  {
    "text": "drug and protein nodes in- in that- that graph was to, um, explore the local and look at the local network neighborhoods for",
    "start": "953750",
    "end": "961490"
  },
  {
    "text": "every node in the graph that are and separates them by distinct edge types. So that is- is achieved to two phases,",
    "start": "961490",
    "end": "969170"
  },
  {
    "text": "where in the first phase for every node, say node v, um, we would de- determine a node's computation graph and",
    "start": "969170",
    "end": "975725"
  },
  {
    "text": "there would be a separate computation graph for each edge type that- uh, that- that exists in the local neighborhood of that node v. And in the second phase, ah,",
    "start": "975725",
    "end": "985444"
  },
  {
    "text": "the idea is to take those computation graphs and learn what is the best way to propagate neural messages along the edges of- um,",
    "start": "985445",
    "end": "994080"
  },
  {
    "text": "of computation graphs and trans- and- and then non-linearly transform them. And so in this particular case,",
    "start": "994080",
    "end": "1000279"
  },
  {
    "text": "we see that for node v, node v has two- uh, two first-order neighbors that are of type r_3,",
    "start": "1000280",
    "end": "1005875"
  },
  {
    "text": "and three second-order neighbors that are of type r_3. So that would be- that would then define",
    "start": "1005875",
    "end": "1012235"
  },
  {
    "text": "a particular computation graph for node v for an edge type r_3 that would, ah, specify how information is propagated along the edges of that edge type.",
    "start": "1012235",
    "end": "1022075"
  },
  {
    "start": "1022000",
    "end": "1151000"
  },
  {
    "text": "So this gives rise to multirelational graph encoder. And in 2018, when the model was developed,",
    "start": "1022075",
    "end": "1028194"
  },
  {
    "text": "the- the architecture was relatively simple. And- and I'm sure you're very familiar with these kind of architectures by this far in the course.",
    "start": "1028195",
    "end": "1035439"
  },
  {
    "text": "So I'll very briefly describe it. Um, the idea here is that in- er, that in Decagon,",
    "start": "1035440",
    "end": "1041380"
  },
  {
    "text": "node embeddings were initialized by, uh, node features, um, which in the case of,",
    "start": "1041380",
    "end": "1047559"
  },
  {
    "text": "um, polypharmacy problem, were um, features representing additional information about",
    "start": "1047560",
    "end": "1053230"
  },
  {
    "text": "drugs and proteins such as drug structure, and protein memberships in pathways, and so on.",
    "start": "1053230",
    "end": "1058315"
  },
  {
    "text": "So embedding for node v and then at layer, um, 0 was just initial, um, node feature of that node.",
    "start": "1058315",
    "end": "1064570"
  },
  {
    "text": "And then at each layer, um, of- uh, of the GNN, the- the embedding for node v was- was",
    "start": "1064570",
    "end": "1071725"
  },
  {
    "text": "updated based on this particular equation which what it did. It look at all possible edge types that- um, uh,",
    "start": "1071725",
    "end": "1078835"
  },
  {
    "text": "that node v was involved in, and for each na- uh, neighbor of node v in that particular edge type,",
    "start": "1078835",
    "end": "1085195"
  },
  {
    "text": "for each neighbor u, um, the- the method took the embedding of that node u from the previous layer k minus 1,",
    "start": "1085195",
    "end": "1092260"
  },
  {
    "text": "it combined that embedding, um, by- er, by, uh, trainable, ah, weight matrix that was",
    "start": "1092260",
    "end": "1098620"
  },
  {
    "text": "specific for the edge type that you're currently looking at. And so to that aggregated result was that",
    "start": "1098620",
    "end": "1104320"
  },
  {
    "text": "co- was then combined with the embedding for node v from the previous layer and non-linearly",
    "start": "1104320",
    "end": "1109809"
  },
  {
    "text": "transformed to get an updated embedding for node v at layer k. Um, the weights for combining the, uh,",
    "start": "1109810",
    "end": "1117485"
  },
  {
    "text": "the- the embedding, the- each- each, um, each nodes embedding from the previous layer as well as the embeddings of the, uh,",
    "start": "1117485",
    "end": "1124070"
  },
  {
    "text": "neighbors at that point was defined by normalization constant, which was fixed based on the node degrees.",
    "start": "1124070",
    "end": "1129620"
  },
  {
    "text": "Today, what- certainly, we would want to use our attention mechanisms. But this particular equation was then applied,",
    "start": "1129620",
    "end": "1135380"
  },
  {
    "text": "um, some large K times where- where large K, would define the number of layers and the final embedding of the, uh,",
    "start": "1135380",
    "end": "1141690"
  },
  {
    "text": "the node is the embedding after K layers of the neighborhood propagation, uh, aggregation schema.",
    "start": "1141690",
    "end": "1147165"
  },
  {
    "text": "So that is fairly standard multi-relational graph encoder by now. So the- the result of multi- uh, uh, uh,",
    "start": "1147165",
    "end": "1154335"
  },
  {
    "start": "1151000",
    "end": "1241000"
  },
  {
    "text": "of the graph encoder were embeddings for drug and protein nodes. And so once em- em- embeddings for those nodes were obtained, um,",
    "start": "1154335",
    "end": "1162345"
  },
  {
    "text": "then the edges were- labeled edges between graph nodes were predicted. And for that the input was, uh, was,",
    "start": "1162345",
    "end": "1169320"
  },
  {
    "text": "em- consists of embeddings of two nodes, C and S. Those would be two particular drugs.",
    "start": "1169320",
    "end": "1174644"
  },
  {
    "text": "And so embeddings of those two nodes, C and S, were combined by, um, um,",
    "start": "1174645",
    "end": "1180840"
  },
  {
    "text": "a particular type of- of tensor factorization, um, that, um, was a- a style of the- tensor factorization that took embeddings for,",
    "start": "1180840",
    "end": "1190305"
  },
  {
    "text": "um, a pair of drug nodes, um, and a combined- and multiplied them by,",
    "start": "1190305",
    "end": "1196125"
  },
  {
    "text": "uh, two diagonal matrices that we're relation specific, and essentially, it encoded in a contribution of specific embedding dimensions towards a particular,",
    "start": "1196125",
    "end": "1205845"
  },
  {
    "text": "um, um, side effect. And then, um, a matrix R, which was, uh, a- a small, uh,",
    "start": "1205845",
    "end": "1211860"
  },
  {
    "text": "um, non- a fully non-zero matrix, um, that, um, allow the model to capture any kind of dependencies",
    "start": "1211860",
    "end": "1219150"
  },
  {
    "text": "between any pair of dimensions in the learned embedding. And so the output was then of- of these decoder were- were",
    "start": "1219150",
    "end": "1225060"
  },
  {
    "text": "then predicted edges of their- for every pair- for every particular side effect,",
    "start": "1225060",
    "end": "1230115"
  },
  {
    "text": "um, the model would return the probability that- that- that a given pair of drugs would interact through that particular side effect.",
    "start": "1230115",
    "end": "1238420"
  },
  {
    "text": "Okay. So in order to then apply this model to the polypharmacy knowledge graph,",
    "start": "1239300",
    "end": "1244920"
  },
  {
    "start": "1241000",
    "end": "1292000"
  },
  {
    "text": "then the first thing to do is to construct the actual polypharmacy knowledge graph. So the data that was used to do so was captured",
    "start": "1244920",
    "end": "1251580"
  },
  {
    "text": "molecular drug and patient data across all drugs prescribed to the US. And for that, a unique dataset was built that consisted of,",
    "start": "1251580",
    "end": "1259365"
  },
  {
    "text": "um, over 4 million drug-drug edges. Those are currently known interactions between pairs and drugs that was,",
    "start": "1259365",
    "end": "1266100"
  },
  {
    "text": "uh, that were retrieved from the FDA. Information on drug-protein edges and information protein-protein edges,",
    "start": "1266100",
    "end": "1273480"
  },
  {
    "text": "as well as site features on nodes. So that gave rise exactly to this multimodal knowledge graph that we have seen earlier,",
    "start": "1273480",
    "end": "1280695"
  },
  {
    "text": "which had over, um, around 5 million edges all together, and it was highly multi-relational as there",
    "start": "1280695",
    "end": "1287639"
  },
  {
    "text": "were 1,000 different edge types in that, um, graph. One is the model where the dataset was constructed,",
    "start": "1287640",
    "end": "1295650"
  },
  {
    "start": "1292000",
    "end": "1336000"
  },
  {
    "text": "um, and, um, Decagon was fully specified. Then, um, the Decagon, uh, uh,",
    "start": "1295650",
    "end": "1301290"
  },
  {
    "text": "model was trained on the polypharmacy, um, knowledge graph in an effort to answer",
    "start": "1301290",
    "end": "1306720"
  },
  {
    "text": "questions of the following form so the users could then pose, uh, a query, uh, for example,",
    "start": "1306720",
    "end": "1311940"
  },
  {
    "text": "whether a form of statin and ciprofloxacin where- which are two drug, when they come together would they lead to breakdown of muscle tissue?",
    "start": "1311940",
    "end": "1320130"
  },
  {
    "text": "That effect should effectively meant that in the backend, that the model was asked with predicting the probability that, uh,",
    "start": "1320130",
    "end": "1326355"
  },
  {
    "text": "these two drugs, um, are connected in the graph by an edge of type r_2,",
    "start": "1326355",
    "end": "1332340"
  },
  {
    "text": "if r_2 would indicate breakdown of muscle tissue. So, um, once the model was trained,",
    "start": "1332340",
    "end": "1338610"
  },
  {
    "start": "1336000",
    "end": "1425000"
  },
  {
    "text": "it was compared against, uh, several baselines, uh, baseline algorithms at that point in time.",
    "start": "1338610",
    "end": "1344130"
  },
  {
    "text": "So these see- the results are shown in the slide, where in the- on the y-axis we see performance,",
    "start": "1344130",
    "end": "1349440"
  },
  {
    "text": "high performer- higher values indicate better performance as me-measured by AUROC and average precision at top 50.",
    "start": "1349440",
    "end": "1355905"
  },
  {
    "text": "And, uh, the performance of Decagon model is shown who read performance of- of- other baselines,",
    "start": "1355905",
    "end": "1363075"
  },
  {
    "text": "um, is, uh, is shown in, um, uh, brown, blue, and green colors. So the particular baselines that we'll consider here was, uh,",
    "start": "1363075",
    "end": "1370605"
  },
  {
    "text": "a simple RESCAL tensor factorization, which can be thought of as Decagon, that does not use the deep graph encoder.",
    "start": "1370605",
    "end": "1376965"
  },
  {
    "text": "And so that test- that test has shown that it's really important to use graph convolutions to learn powerful embeddings.",
    "start": "1376965",
    "end": "1383715"
  },
  {
    "text": "So then Decagon was compared to a multi-relational factorization, which is as, uh, which, um, um,",
    "start": "1383715",
    "end": "1391044"
  },
  {
    "text": "any- the- the relative improvement of Decagon over that factorization showed that it's- it's really",
    "start": "1391045",
    "end": "1396230"
  },
  {
    "text": "important to be able to model side effects jointly because there are some correlations between side effects.",
    "start": "1396230",
    "end": "1402230"
  },
  {
    "text": "And- and finally, then, uh, Decagon was compared to a shallow network embedding model, um, embedding model which was a node2vec style model.",
    "start": "1402230",
    "end": "1410554"
  },
  {
    "text": "Um, and the improvement there showed that, um, the- the- the new- the message passing network is- is",
    "start": "1410555",
    "end": "1416630"
  },
  {
    "text": "much better in- in terms of performance in this particular application, uh, than, uh, some of the random walk,",
    "start": "1416630",
    "end": "1422540"
  },
  {
    "text": "uh, based, uh, embeddings at the time. So another test that was done was to,",
    "start": "1422540",
    "end": "1427880"
  },
  {
    "start": "1425000",
    "end": "1512000"
  },
  {
    "text": "um, do, um, apply Decagon in a temporal fashion. Meaning, the Decagon was trained on all the data generated prior to 2012.",
    "start": "1427880",
    "end": "1435845"
  },
  {
    "text": "And then, uh, the model was frozen and it was asked to make predictions,",
    "start": "1435845",
    "end": "1441400"
  },
  {
    "text": "um, that the model is most confident about. And we then test that, well, how many of those prediction have been confirmed after 2012?",
    "start": "1441400",
    "end": "1449235"
  },
  {
    "text": "So what is shown in this particular slide is our top 10 predictions made by the model, and so we- we recorded.",
    "start": "1449235",
    "end": "1454665"
  },
  {
    "text": "Each prediction comes in the form of a pair of drugs and the side effects associated with that pair of drugs.",
    "start": "1454665",
    "end": "1460095"
  },
  {
    "text": "And so for five out of those top ten predictions, direct evidence was found, published after 2012, um,",
    "start": "1460095",
    "end": "1467190"
  },
  {
    "text": "showing that- it- showing examples of real patients who were on a particular combination of drugs and have experienced",
    "start": "1467190",
    "end": "1474915"
  },
  {
    "text": "the kind of side effect the data has actually predicted would happen. So for example, for drug, uh, prediction number 8,",
    "start": "1474915",
    "end": "1481485"
  },
  {
    "text": "the- there- there are several reports of- of patients who took, a statin and amlodipine together and experienced muscle inflammation.",
    "start": "1481485",
    "end": "1490034"
  },
  {
    "text": "And those reports were made after 2012 and- which is- which provides evidence for- for- for prediction made by the model.",
    "start": "1490034",
    "end": "1497940"
  },
  {
    "text": "Some of the novel predictions in this space are novel hypotheses that can- that warrant further analysis and- and",
    "start": "1497940",
    "end": "1503970"
  },
  {
    "text": "downstream investigations in several collaborations with domain experts who are in- working",
    "start": "1503970",
    "end": "1509010"
  },
  {
    "text": "these disease and drug areas that has actually been done. Um, and- and, uh, a re- more recent follow-up, um,",
    "start": "1509010",
    "end": "1515385"
  },
  {
    "start": "1512000",
    "end": "1589000"
  },
  {
    "text": "on the Decagon study is concerned with modeling adverse events at the level of patient groups in an effort to",
    "start": "1515385",
    "end": "1522660"
  },
  {
    "text": "make predictions about what are adverse events that might be associated with certain group of individuals.",
    "start": "1522660",
    "end": "1530460"
  },
  {
    "text": "There were- those groups can be defined by age, by gender, or by individuals that have certain kinds of certain diseases.",
    "start": "1530460",
    "end": "1537630"
  },
  {
    "text": "And so, um, what- what- I'm mentioning this because, um, the data is already, um,",
    "start": "1537630",
    "end": "1543150"
  },
  {
    "text": "preprocessed and provided to the study, um, and- and so those who are interested in potentially leveraging",
    "start": "1543150",
    "end": "1548490"
  },
  {
    "text": "GNNs for doing more personalized level adverse event prediction, which is certainly something that can- that is possible now to do with",
    "start": "1548490",
    "end": "1555645"
  },
  {
    "text": "this dataset that contains over 10 million ad- adverse event reports. Okay. So [NOISE] this concludes my- my first, um,",
    "start": "1555645",
    "end": "1562980"
  },
  {
    "text": "vignette or first pa- topic- a large topic for today. And the next topic, we'll- we'll change the gears,",
    "start": "1562980",
    "end": "1569325"
  },
  {
    "text": "and we will move away from predicting safety of drugs. Instead, now we will, um,",
    "start": "1569325",
    "end": "1575655"
  },
  {
    "text": "we will think about diagnosing patients, which is important crucial question that, uh,",
    "start": "1575655",
    "end": "1581865"
  },
  {
    "text": "first need to be answered before any drugs can be actually- or treatments can be actually identified and recommended to the patient.",
    "start": "1581865",
    "end": "1589275"
  },
  {
    "start": "1589000",
    "end": "1736000"
  },
  {
    "text": "So let me start with the motivation of disease diagnosis. Uh, so, um, the core information for disease,",
    "start": "1589275",
    "end": "1598500"
  },
  {
    "text": "uh, uh, for diagnosing the disease, broadly speaking, is the information about phenotypes that are seen and observed in a particular patient.",
    "start": "1598500",
    "end": "1607080"
  },
  {
    "text": "So phenotypes can be defined as some observable characteristics that,",
    "start": "1607080",
    "end": "1612705"
  },
  {
    "text": "uh, that um, can be seen, er, uh, in- in a patient, and they result from various interactions between",
    "start": "1612705",
    "end": "1619680"
  },
  {
    "text": "the genotype and the genomic information within the patient as well as, um, environment in which the patient lives. So physicians typically utilize, uh,",
    "start": "1619680",
    "end": "1628440"
  },
  {
    "text": "various standardized vocabularies of phenotypes to describe human diseases. For example, a very prominent standardized voca- vocabulary phenotypes",
    "start": "1628440",
    "end": "1637860"
  },
  {
    "text": "is known hu- as human phenotype, uh, um, ontology. And, um, that codifies there- uh,",
    "start": "1637860",
    "end": "1646019"
  },
  {
    "text": "a variety of different phenotypes and how they map to human diseases. So by mo- by- by modeling diseases then as collections",
    "start": "1646020",
    "end": "1653205"
  },
  {
    "text": "of phenotypes or- or that represent the disease, we can then diagnose patients based on what are the phenotypes that they have,",
    "start": "1653205",
    "end": "1661575"
  },
  {
    "text": "based on what are the symptoms that those patients would have. So in machine learning, we can define the diagnosis task then in the following manner.",
    "start": "1661575",
    "end": "1670395"
  },
  {
    "text": "Uh, we will start with a graph. Consi- consider for- in this particular example, a graph that is built from the standardized vocabulary phenotypes.",
    "start": "1670395",
    "end": "1677910"
  },
  {
    "text": "That would be a graph where nodes are phenotypes that- those might be visible symptoms as well as various phenotypes of the molecular or genomic level.",
    "start": "1677910",
    "end": "1686789"
  },
  {
    "text": "And edges between those phenotypic nodes would indicate different kinds of relationships between phenotypes.",
    "start": "1686790",
    "end": "1692610"
  },
  {
    "text": "We can then- in- in- in that setting, the disease would then be represented as a set of nodes or",
    "start": "1692610",
    "end": "1697620"
  },
  {
    "text": "a subgraph in that, uh, phenotypic network. So the learning task would then be the diagnosis test,",
    "start": "1697620",
    "end": "1704760"
  },
  {
    "text": "is then concerned with- with predicting the, uh, the label or predicting the disease that is most consistent with,",
    "start": "1704760",
    "end": "1712460"
  },
  {
    "text": "uh, a particular subgraph S that describes the patient. So you can think of now that patients are",
    "start": "1712460",
    "end": "1718820"
  },
  {
    "text": "these different subgraphs of phenotypes the patients have, and the goal is to predict labels,",
    "start": "1718820",
    "end": "1725420"
  },
  {
    "text": "which in this particular case are colors of the subgraphs, and those labels are the diseases that, uh,",
    "start": "1725420",
    "end": "1731195"
  },
  {
    "text": "the- that- that are, uh, candidate diseases patients might have. Okay. So, if- given this formulation, uh, let's, uh,",
    "start": "1731195",
    "end": "1740085"
  },
  {
    "start": "1736000",
    "end": "1798000"
  },
  {
    "text": "let's discuss the algorithm for this problem a bit and then we will return back to the data in the diagnosis task.",
    "start": "1740085",
    "end": "1746220"
  },
  {
    "text": "So in the context of graph neural network, our problem formulation is the following. The goal here will be actually to learn embeddings for subgraphs such that,",
    "start": "1746220",
    "end": "1756270"
  },
  {
    "text": "uh, uh, those embeddings for, uh, the- the- for subgraphs that are learned, we capture well, uh, the topology of",
    "start": "1756270",
    "end": "1762674"
  },
  {
    "text": "interactions between nodes as well as where they are, where they exist in the context of,",
    "start": "1762675",
    "end": "1768075"
  },
  {
    "text": "um, the underlying graph. So that means that, um, that the input, um,",
    "start": "1768075",
    "end": "1773700"
  },
  {
    "text": "which then consists of the- some underlying graph G and a large number of subgraphs that have labels,",
    "start": "1773700",
    "end": "1780615"
  },
  {
    "text": "and the goal is to learn subgraph embedding such that two subgraphs is a pioneer Sub_j, that have similar subgraph topology,",
    "start": "1780615",
    "end": "1787380"
  },
  {
    "text": "and I will define next what that means. They should be embedded close together in the embedding space,",
    "start": "1787380",
    "end": "1792570"
  },
  {
    "text": "so representing by nearby points in the embedding space that you want to learn.",
    "start": "1792570",
    "end": "1798029"
  },
  {
    "start": "1798000",
    "end": "1885000"
  },
  {
    "text": "So why are subgraphs challenging? So why can we, for example, just take our favorite node level embedder,",
    "start": "1798030",
    "end": "1804945"
  },
  {
    "text": "and by now, I'm sure you have heard of many node level embedders in the course, and essentially, just learned node embeddings and- and",
    "start": "1804945",
    "end": "1811410"
  },
  {
    "text": "taken every- of those node embeddings or somehow, um, aggregate those node embeddings to arrive at a subgraph embedding.",
    "start": "1811410",
    "end": "1817965"
  },
  {
    "text": "So there are several reasons why we- we might lose a lot of information if you do so.",
    "start": "1817965",
    "end": "1823544"
  },
  {
    "text": "So one of them is that, um, the subgraphs that we would encounter in the diagnosis task, um, are subgraphs of varying sizes.",
    "start": "1823545",
    "end": "1830669"
  },
  {
    "text": "And, um, then the question is really, how to represent those subgraphs effectively that are not simple k-hop neighborhoods around a sing- a- a single center node.",
    "start": "1830670",
    "end": "1840420"
  },
  {
    "text": "Second, subgraphs could- could- would have reached connectivity structures both internally as well as externally to interactions with the rest of the graph.",
    "start": "1840420",
    "end": "1849690"
  },
  {
    "text": "So how can you inject that information into our GNNs? And finally, subgraphs that are given by,",
    "start": "1849690",
    "end": "1856860"
  },
  {
    "text": "uh, sets of, uh, phenotypes for patients can be localized in the sense that they would reside in a single region,",
    "start": "1856860",
    "end": "1864450"
  },
  {
    "text": "in a single large neighborhood of the graph, such as this hypothetical example where the subgraph is",
    "start": "1864450",
    "end": "1870419"
  },
  {
    "text": "indicated by this red blob that is core to the center of core of the graph, or subgraphs may be distributed across many multiple local neighborhoods.",
    "start": "1870420",
    "end": "1878880"
  },
  {
    "text": "And so, um, then, uh, a simple averaging of node embeddings might not be an effective strategy.",
    "start": "1878880",
    "end": "1885105"
  },
  {
    "start": "1885000",
    "end": "1967000"
  },
  {
    "text": "So to tackle this problem, uh, what was developed was a subgraph neural network model.",
    "start": "1885105",
    "end": "1890145"
  },
  {
    "text": "And so the problem that subgraph neural network is solving is the following. It assumes that given are some set of subgraphs S,",
    "start": "1890145",
    "end": "1898395"
  },
  {
    "text": "the set has an, uh, n subgraphs, S_1, S_2 up to S_n. SubGNN specifies then a neural message passing architecture that will generate,",
    "start": "1898395",
    "end": "1907050"
  },
  {
    "text": "um, D then- Dsub as dimensional subgraph representation for every subgraph in that set.",
    "start": "1907050",
    "end": "1913455"
  },
  {
    "text": "And would- they'll use those representations to learn a subgraph level classifier. So a function that will then map those subgraphs to some number of discrete labels.",
    "start": "1913455",
    "end": "1924450"
  },
  {
    "text": "And the way it will do so is by really taking into account different kinds of subgraph topology, in particular,",
    "start": "1924450",
    "end": "1932490"
  },
  {
    "text": "the- the parts of subgraph topology to- to- you're interested in, is related to capturing the connectivity within the immediate local neighborhood of, uh,",
    "start": "1932490",
    "end": "1941940"
  },
  {
    "text": "each subgraph, both, uh, the internal in- in- with- within a subgraph as well as at the border of the subgraph in the, uh, um,",
    "start": "1941940",
    "end": "1949784"
  },
  {
    "text": "the graph G. The information about the structure of the subgraph in the sense of other certain motifs that are over or underrepresented in a subgraph,",
    "start": "1949785",
    "end": "1957945"
  },
  {
    "text": "as well as where is that subgraph located relative to the graph G in- in- in which,",
    "start": "1957945",
    "end": "1964279"
  },
  {
    "text": "uh, it, uh, it exists. So a- as a quick note on problem formulation that I want to- to give",
    "start": "1964280",
    "end": "1971669"
  },
  {
    "start": "1967000",
    "end": "2010000"
  },
  {
    "text": "here is that SubGNN puts forward a definition of subgraph prediction learning task.",
    "start": "1971670",
    "end": "1977520"
  },
  {
    "text": "Um, this is different from other canonical tasks on graphs that are primarily concerned with a node level predictions",
    "start": "1977520",
    "end": "1985320"
  },
  {
    "text": "and representations where the goal is to predict properties, um, from- of an individual node in the graph,",
    "start": "1985320",
    "end": "1991125"
  },
  {
    "text": "or link prediction which is concerned with predicting properties of a pair of nodes, or graph level prediction,",
    "start": "1991125",
    "end": "1997200"
  },
  {
    "text": "which is concerned with predicting properties of entire graphs. So SubGNN is concerned with predicting properties of subgraphs of non-trivial size,",
    "start": "1997200",
    "end": "2006409"
  },
  {
    "text": "meaning, not subgraphs of size just 2, which would correspond on edge. The way this is done is that SubGNN consists of two parts.",
    "start": "2006410",
    "end": "2013985"
  },
  {
    "start": "2010000",
    "end": "2180000"
  },
  {
    "text": "So the first important part is, uh, message passing scheme that is hierarchical in nature,",
    "start": "2013985",
    "end": "2019294"
  },
  {
    "text": "and it specifies the way neural messages are propagated from anchor patches, which are helper graphs sampled from G to subgraphs S that, uh,",
    "start": "2019295",
    "end": "2029029"
  },
  {
    "text": "we want to embed, and how those messages are then embedded- um, aggregated to arrive at the final subgraph embedding.",
    "start": "2029030",
    "end": "2036425"
  },
  {
    "text": "And in part 3 the- uh, in part 2, that routing of messages is really down to three distinct channels where",
    "start": "2036425",
    "end": "2042950"
  },
  {
    "text": "each channel corresponds to a part- distinct aspect of subgraph topology, position, neighborhood, and structure if you want to capture.",
    "start": "2042950",
    "end": "2050014"
  },
  {
    "text": "Uh, very blief- briefly, let me describe these two parts. So the subgraph message passing, uh,",
    "start": "2050015",
    "end": "2056014"
  },
  {
    "text": "scheme is- has the following structure. Um, there are, um, um,",
    "start": "2056015",
    "end": "2061730"
  },
  {
    "text": "neural messages s- specified to those messages are specific for each of the three properties.",
    "start": "2061730",
    "end": "2067834"
  },
  {
    "text": "So they're denoted in sub x, and those messages are propagated from anchor patches to subgraph components.",
    "start": "2067834",
    "end": "2075440"
  },
  {
    "text": "Anchor patches are just helper subgraphs that are sampled randomly from the underlying graph G,",
    "start": "2075440",
    "end": "2081590"
  },
  {
    "text": "and there are three different kinds of patches depending of the- of the- to capture for, uh, to capture position, neighborhood, and structure.",
    "start": "2081590",
    "end": "2089014"
  },
  {
    "text": "So, um, then the- the- the message passing",
    "start": "2089015",
    "end": "2094159"
  },
  {
    "text": "is then formulated as the message from this anchor patch A to subgraphs S,",
    "start": "2094160",
    "end": "2099305"
  },
  {
    "text": "um, is, uh, is sent and it's scored based on its weight. Its contribution is weighted by similarity function between a subgraph component in",
    "start": "2099305",
    "end": "2107810"
  },
  {
    "text": "an anchor patch that- that- that represents a weight of how much an embedding of the anchor patch will,",
    "start": "2107810",
    "end": "2114170"
  },
  {
    "text": "uh, contribute to embedding of the subgraph. So this is visually shown here in the right part of the slide where the-",
    "start": "2114170",
    "end": "2120589"
  },
  {
    "text": "the subgraph that- that is part of the data that you want to embed is S_1. This subgraph actually has two disconnected components.",
    "start": "2120590",
    "end": "2128660"
  },
  {
    "text": "It- one is here, um, um, on the left part and the right part of the, uh, the-",
    "start": "2128660",
    "end": "2133805"
  },
  {
    "text": "the right, uh, uh, extreme of the graph, and in the message passing phase, uh, those helper patches- um,",
    "start": "2133805",
    "end": "2140630"
  },
  {
    "text": "anchor patches which are in gray, send their messages to the subgraph component. Those set of messages that are received at the subgraph component are aggregated,",
    "start": "2140630",
    "end": "2150060"
  },
  {
    "text": "and then the- the aggregated message of the subgraph component is combined with its previous components- uh,",
    "start": "2150060",
    "end": "2157420"
  },
  {
    "text": "with its previous embedding to get a property specific representation of, uh, subgraph component.",
    "start": "2157420",
    "end": "2164395"
  },
  {
    "text": "So H_x c is then an embedding for, um, subgraph component c,",
    "start": "2164395",
    "end": "2170200"
  },
  {
    "text": "so it could be just for this fir- one component of the subgraph S_1, ah, that captures the aspect x,",
    "start": "2170200",
    "end": "2177520"
  },
  {
    "text": "which can be position, neighborhood, or structure. So the way this message passing is done,",
    "start": "2177520",
    "end": "2182540"
  },
  {
    "start": "2180000",
    "end": "2251000"
  },
  {
    "text": "is done in three separate channels. And each channel, it describes, um, a particular- uh,",
    "start": "2182540",
    "end": "2188135"
  },
  {
    "text": "it's designed to capture one aspect of topology, position, neighborhood, and structure. Each channel x has three key co- elements.",
    "start": "2188135",
    "end": "2195635"
  },
  {
    "text": "Those elements are similarity function that weighs, um, messages exchange between anchor patches and subgraph components.",
    "start": "2195635",
    "end": "2203555"
  },
  {
    "text": "Then a sa- uh, an anchor patch sampling function that specifies how these helper patches need to",
    "start": "2203555",
    "end": "2210349"
  },
  {
    "text": "be sampled from the underlying graph in order to capture, um, neighborhood or see- and- and capture",
    "start": "2210350",
    "end": "2216560"
  },
  {
    "text": "diverse neighborhoods and diverse structure and diverse positions. And finally, how to encode those anchor patches,",
    "start": "2216560",
    "end": "2222125"
  },
  {
    "text": "and these functions can be learned or predefined. And so the recap of that,",
    "start": "2222125",
    "end": "2227465"
  },
  {
    "text": "is that we can think of this problem as, um, uh, as the- as the problem of learning subgraph representations as, um, uh,",
    "start": "2227465",
    "end": "2235520"
  },
  {
    "text": "as- as a message passing network that has three distinct channels, and those channels output, um,",
    "start": "2235520",
    "end": "2241025"
  },
  {
    "text": "channel specific embeddings that are then aggregated to produce",
    "start": "2241025",
    "end": "2246260"
  },
  {
    "text": "a final subgraph representation Z_s for subgraph S. So let's now return to our problem of, uh, disease diagnosis.",
    "start": "2246260",
    "end": "2255365"
  },
  {
    "start": "2251000",
    "end": "2353000"
  },
  {
    "text": "And the first thing we will do, we will, uh, ask- we will- we will test whether that method works on",
    "start": "2255365",
    "end": "2262085"
  },
  {
    "text": "some simulated synthetic datasets to really see whether the method can truly captured the distinct aspects of subgraph topology.",
    "start": "2262085",
    "end": "2269255"
  },
  {
    "text": "And the set up for that was the following. In each case, each dataset started with the base graph, um,",
    "start": "2269255",
    "end": "2277295"
  },
  {
    "text": "and base graph was then, um, sprinkled, um, with a large number of subgraphs.",
    "start": "2277295",
    "end": "2283430"
  },
  {
    "text": "There were two strategies to define subgraphs, either to- one strategy was- uh, was the planting strategy where a subgraph was generated",
    "start": "2283430",
    "end": "2290450"
  },
  {
    "text": "and it was planted on top of the base graph, or it would be essential- essentially just joined in the form of- uh,",
    "start": "2290450",
    "end": "2297455"
  },
  {
    "text": "in similar way as it would be stable together with the base graph. In this particular subgraph- er,",
    "start": "2297455",
    "end": "2302569"
  },
  {
    "text": "in this particular synthetical datasets, each sub- for each subgraph, a label was defined.",
    "start": "2302570",
    "end": "2307849"
  },
  {
    "text": "And so labels were defined based on certain network structural properties of those subgraphs.",
    "start": "2307850",
    "end": "2313430"
  },
  {
    "text": "So one particular synthetic dataset was called density, where- that was a dataset where, um,",
    "start": "2313430",
    "end": "2319460"
  },
  {
    "text": "that consists of the underlying base graph with the- and then a large number of subgraphs,",
    "start": "2319460",
    "end": "2324965"
  },
  {
    "text": "the labels of those subgraphs were binned values of density network, density metric.",
    "start": "2324965",
    "end": "2330920"
  },
  {
    "text": "And similar datasets were constructed for- that, uh, based on- on cut ratio metric, coreness, and component.",
    "start": "2330920",
    "end": "2337700"
  },
  {
    "text": "Why would you want to do that? The idea was to do that to test whether",
    "start": "2337700",
    "end": "2342859"
  },
  {
    "text": "really the most informative channels for certain types of labels are those channels that really truly determine the label.",
    "start": "2342859",
    "end": "2350030"
  },
  {
    "text": "So this is really a controlled environment of testing performance of the model. And so- thus results show that SubGNN is an effective strategy for",
    "start": "2350030",
    "end": "2359900"
  },
  {
    "start": "2353000",
    "end": "2606000"
  },
  {
    "text": "learning subgraph embeddings that outperforms various simple adhoc measures that one could think of.",
    "start": "2359900",
    "end": "2365750"
  },
  {
    "text": "For example, um, taking a simple average of node embeddings at- and- and obtain subgrapgh embeddings in this way,",
    "start": "2365750",
    "end": "2373520"
  },
  {
    "text": "or introduce a meta artificial note and then embed those meta nodes that could serve as proxies for subgraph embeddings or even doing graph level embeddings.",
    "start": "2373520",
    "end": "2383615"
  },
  {
    "text": "Finally, this- these results also showed that the SubGNN can capture well different aspects of subgraph topology.",
    "start": "2383615",
    "end": "2389914"
  },
  {
    "text": "That was can be studied by looking what- which of the three channels; neighborhood,",
    "start": "2389915",
    "end": "2395120"
  },
  {
    "text": "position, or structure, would be most informative for predicting certain kinds of labels.",
    "start": "2395120",
    "end": "2400970"
  },
  {
    "text": "So for the case of density, um, the label would primarily be determined by,",
    "start": "2400970",
    "end": "2406385"
  },
  {
    "text": "uh, the neighborhood of the subgraphs. So what was then tested is whether the neighborhood channel is most informative for predicting the density labels,",
    "start": "2406385",
    "end": "2415175"
  },
  {
    "text": "and indeed, that was the case. Okay. So now that, uh, we- we know that SubGNN works well,",
    "start": "2415175",
    "end": "2421045"
  },
  {
    "text": "let's return to our real-world dataset. So there were four real-world datasets that were designed for the problem of,",
    "start": "2421045",
    "end": "2427225"
  },
  {
    "text": "uh, um, clinical diagnostic tests. So each of the four datasets consists of a base graph,",
    "start": "2427225",
    "end": "2433779"
  },
  {
    "text": "and sub-graphs with associated labels. So the two, uh,",
    "start": "2433780",
    "end": "2439290"
  },
  {
    "text": "datasets that I want to bring your attention to are called HPO-METAB and HPO-NEURO.",
    "start": "2439290",
    "end": "2444935"
  },
  {
    "text": "So these are the datasets where the base graph is the graph of- um, from the human phenotype ontology.",
    "start": "2444935",
    "end": "2451955"
  },
  {
    "text": "So this is a graph where nodes are human phenotypes, and just are hierarchical relationships between",
    "start": "2451955",
    "end": "2457145"
  },
  {
    "text": "phenotypes and symptoms that we see in human populations. And then labels are defined by certain- uh, by, uh,",
    "start": "2457145",
    "end": "2465110"
  },
  {
    "text": "then subgraphs are defined by subgraphs of metabolic, um, uh, diseases and metabolic disorders that, uh, affect humans.",
    "start": "2465110",
    "end": "2474575"
  },
  {
    "text": "And in the HPO-NEURO dataset, then subgraphs represent, um,",
    "start": "2474575",
    "end": "2480890"
  },
  {
    "text": "uh, various neurodegenerative diseases. So the goal of those two- uh, uh, those- these two particular datasets is to, um, define- er,",
    "start": "2480890",
    "end": "2490220"
  },
  {
    "text": "is to predict subgraph labels that correspond to various metabolic or neurological diseases",
    "start": "2490220",
    "end": "2497105"
  },
  {
    "text": "that are consistent with the underlying phenotypes. So this simulates the environment of diagnosing",
    "start": "2497105",
    "end": "2503240"
  },
  {
    "text": "patients that might have metabolic or neurological disorders. So let's see performance of SubGNN,",
    "start": "2503240",
    "end": "2509479"
  },
  {
    "text": "uh, across those, um, four datasets with a particular focus on the,",
    "start": "2509479",
    "end": "2514670"
  },
  {
    "text": "uh, human phenotype ontology, neuro and metabolic dataset. And so what we can see is that the performance of SubGNN when- when,",
    "start": "2514670",
    "end": "2524060"
  },
  {
    "text": "uh, implemented with, uh, um, uh, when, uh- when compared to, um,",
    "start": "2524060",
    "end": "2531095"
  },
  {
    "text": "baseline motto- models is substantially better, and SubGNN outperforms though- those, uh,",
    "start": "2531095",
    "end": "2537275"
  },
  {
    "text": "baseline met- models considered here by up to 125%,",
    "start": "2537275",
    "end": "2542539"
  },
  {
    "text": "which is a- which is a really incredible improvement in performance, which clearly motivates the use of subgraphs rather than simply,",
    "start": "2542540",
    "end": "2551930"
  },
  {
    "text": "um, considering note level or graph level aggregation.",
    "start": "2551930",
    "end": "2556079"
  },
  {
    "text": "Okay, um, so this concludes the second part of, uh, the stock, which was concerned with,",
    "start": "2557340",
    "end": "2563785"
  },
  {
    "text": "um, using the power of subgraph embeddings and GNS for disease diagnosis tasks.",
    "start": "2563785",
    "end": "2570595"
  },
  {
    "text": "And in the first- the third part of the talk, I will, uh, focus on se- important endpoint for drug development,",
    "start": "2570595",
    "end": "2578680"
  },
  {
    "text": "which is that of drug efficacy. So in the first part we talked about drug safety but, uh,",
    "start": "2578680",
    "end": "2583795"
  },
  {
    "text": "in drugs and safety is one of two cornered endpoints that we care about in drug development process.",
    "start": "2583795",
    "end": "2591130"
  },
  {
    "text": "In addition to drug safety, the second important endpoint is efficacy, where the question is to understand,",
    "start": "2591130",
    "end": "2597220"
  },
  {
    "text": "whether a certain molecule that might be candidate drug wi- will really have positive therapeutic effect in patients.",
    "start": "2597220",
    "end": "2604345"
  },
  {
    "text": "So let's, uh, start with this third part of the talk. The motivating factor- the- the motivating,",
    "start": "2604345",
    "end": "2611245"
  },
  {
    "start": "2606000",
    "end": "2799000"
  },
  {
    "text": "uh, problem for this, uh, task was, uh, the question of how to find cures for emerging diseases.",
    "start": "2611245",
    "end": "2617650"
  },
  {
    "text": "This particular, uh, work was motivated by the onset of the COVID pandemic last year,",
    "start": "2617650",
    "end": "2623140"
  },
  {
    "text": "uh, where- um, it was- became clear that, uh, at the- them, uh, at the beginning of the pandemic, uh, there, um,",
    "start": "2623140",
    "end": "2632440"
  },
  {
    "text": "the need was for rapid de- deployment and identification of drugs that might have positive therapeutic effect in, uh,",
    "start": "2632440",
    "end": "2639040"
  },
  {
    "text": "in COVID-19 patients but simply traditional approaches of iterative development,",
    "start": "2639040",
    "end": "2644589"
  },
  {
    "text": "experimental testing, and clinical validation, and approval of new drugs were not feasible because they- they, on average,",
    "start": "2644589",
    "end": "2651130"
  },
  {
    "text": "take over a decade to bring and des- design a new drug from scratch and bring it to market and that was simply not feasible.",
    "start": "2651130",
    "end": "2658480"
  },
  {
    "text": "So a more realistic strategy relied on repurposing of drugs, requiring has to essentially identify",
    "start": "2658480",
    "end": "2665035"
  },
  {
    "text": "what other drugs that are clinically approved that might have therapeutic effect in COVID-19 patients",
    "start": "2665035",
    "end": "2671275"
  },
  {
    "text": "and so the particular study that I will be mentioning is, uh, is the- is the one that was",
    "start": "2671275",
    "end": "2677635"
  },
  {
    "text": "conducted bet- that it started at the beginning of March last year, and the most parts of it were done between March and, uh,",
    "start": "2677635",
    "end": "2686140"
  },
  {
    "text": "last summer and it really demonstrates, uh, an opportunity of how, in this particular case,",
    "start": "2686140",
    "end": "2691570"
  },
  {
    "text": "graph neural networks were able to compress years of work into actually weeks,",
    "start": "2691570",
    "end": "2697210"
  },
  {
    "text": "in some cases actually days of work by- by- through very close collaboration between machine learning models,",
    "start": "2697210",
    "end": "2703630"
  },
  {
    "text": "predictions that are provided by those models and end-users, which in this case, were virologists and experimental biologists who took",
    "start": "2703630",
    "end": "2711010"
  },
  {
    "text": "predictions and experimentally screened and intellect. Okay, so that's- this is our goal for- for this part of the talk.",
    "start": "2711010",
    "end": "2722620"
  },
  {
    "text": "Let's- let's now try to, uh, uh, unpack and define the problem of drug repurposing first and then describe our technical approach for- for- for this problem.",
    "start": "2722620",
    "end": "2730990"
  },
  {
    "text": "So as I mentioned, the discovery of a new development of new drug from scratch is a very lengthy resource intensive process.",
    "start": "2730990",
    "end": "2738250"
  },
  {
    "text": "It, on average, takes more than a decade and it costs 1-2 billion dollars to design a new drug from scratch.",
    "start": "2738250",
    "end": "2744580"
  },
  {
    "text": "And so, faced with the skyrocketing costs for developing new drugs, researchers are looking at ways to repurpose older ones,",
    "start": "2744580",
    "end": "2752185"
  },
  {
    "text": "to essentially take drugs that are already on the market and ask, are there any other kind of diseases that those drugs might be effective in?",
    "start": "2752185",
    "end": "2761065"
  },
  {
    "text": "And that is very appealing strategy because it would be much shorter and potentially much more effective.",
    "start": "2761065",
    "end": "2767545"
  },
  {
    "text": "Most famous example of a drug that was repurpose on the market is- is- is",
    "start": "2767545",
    "end": "2774190"
  },
  {
    "text": "Viagra that was initially designed for treating cardiovascular diseases but then during clinical trials,",
    "start": "2774190",
    "end": "2779890"
  },
  {
    "text": "it turned out that there might be other indications that it would be useful for. And so while in the past, those repurposing, uh,",
    "start": "2779890",
    "end": "2786940"
  },
  {
    "text": "strategies were primarily coincidental findings, there is now a concerted effort of,",
    "start": "2786940",
    "end": "2793255"
  },
  {
    "text": "\"Can we systematically go through drugs that are, uh, clinically approved in the market and identify possible therapeutic opportunities?\"",
    "start": "2793255",
    "end": "2799914"
  },
  {
    "start": "2799000",
    "end": "2848000"
  },
  {
    "text": "So the core of this question or the core of this problem is the following question, which we can think of it as a link prediction problem in- in a bar touch graph,",
    "start": "2799915",
    "end": "2808285"
  },
  {
    "text": "where on the left we have a set of drugs. Those might be all approved drugs plus investigational experimental drugs, um,",
    "start": "2808285",
    "end": "2815080"
  },
  {
    "text": "some drugs that fails in clinical trials, but otherwise are not hugely, uh,",
    "start": "2815080",
    "end": "2820195"
  },
  {
    "text": "unsafe for patient, and on the right, we would have tens of thousands of diseases which are codified diseases,",
    "start": "2820195",
    "end": "2826405"
  },
  {
    "text": "uh, that could be described, for example, two set of phenotypes that we were discussing in the second part of the talk.",
    "start": "2826405",
    "end": "2832620"
  },
  {
    "text": "So edges connecting drugs to diseases here would indicate the known treatment relationships.",
    "start": "2832620",
    "end": "2837645"
  },
  {
    "text": "The problem that we have here- our goal is to have a model that would predict what diseases,",
    "start": "2837645",
    "end": "2843135"
  },
  {
    "text": "uh, a- a new molecule or an existing drug might treat. So is this a challenging problem?",
    "start": "2843135",
    "end": "2849940"
  },
  {
    "start": "2848000",
    "end": "2932000"
  },
  {
    "text": "Why is finding treatments for a new disease in particular, such a challenging problem.",
    "start": "2849940",
    "end": "2854950"
  },
  {
    "text": "So when we're conc- we're- when we're concerned with the question of ho- finding treatment for a new emerging disease,",
    "start": "2854950",
    "end": "2861100"
  },
  {
    "text": "that means that we want to identify drugs that may treat the disease,",
    "start": "2861100",
    "end": "2866110"
  },
  {
    "text": "but there are no currently known drugs for that disease. So, and COVID was a very, very prominent example of that na- i- the- uh,",
    "start": "2866110",
    "end": "2873610"
  },
  {
    "text": "la- early, uh, last, uh, year. And so conceptual- technically that means- that- that's not surprising because we know in machine learning,",
    "start": "2873610",
    "end": "2881859"
  },
  {
    "text": "that generalizing to new phenomena is typically hard. Prevailing graph neural network methods still assume and require",
    "start": "2881860",
    "end": "2888670"
  },
  {
    "text": "abundant label information in order to be really trained effectively and achieve high accuracy.",
    "start": "2888670",
    "end": "2894415"
  },
  {
    "text": "However, I would argue that one of the definitive factors of frontier of biology and medicine are",
    "start": "2894415",
    "end": "2901539"
  },
  {
    "text": "problems were labeled examples are incredibly scarce and this includes emergent diseases such as COVID-19,",
    "start": "2901540",
    "end": "2909220"
  },
  {
    "text": "rare diseases, hard to diagnose patients, modeling novel drugs in development and many, many other problems.",
    "start": "2909220",
    "end": "2915055"
  },
  {
    "text": "So what prevailing methods assume is that we start with drugs that are already richly labeled.",
    "start": "2915055",
    "end": "2920410"
  },
  {
    "text": "That assumption is heavily violated in most exciting problems where in reality what happens in the world that we only have a handful of labels,",
    "start": "2920410",
    "end": "2927880"
  },
  {
    "text": "uh, for a particular class, if any at all. So too- for- for the- for the problem of drug repurposing, that, uh,",
    "start": "2927880",
    "end": "2937750"
  },
  {
    "start": "2932000",
    "end": "3067000"
  },
  {
    "text": "in the- in the meta da- and the gene and methodology that I will describe, it really relies on few-short learning and meta-learning.",
    "start": "2937750",
    "end": "2944530"
  },
  {
    "text": "So I have two slides now with just a very brief high-level overview of that, uh, of what metal learning is and I assume that many",
    "start": "2944530",
    "end": "2951340"
  },
  {
    "text": "have already heard about this in o- in other courses. So, uh, meta-learning is",
    "start": "2951340",
    "end": "2957490"
  },
  {
    "text": "very effective strategy for- for learning in the cases where there are a very few small number of",
    "start": "2957490",
    "end": "2963849"
  },
  {
    "text": "labeled examples available for- for- for tasks and so typically, the idea of, uh,",
    "start": "2963850",
    "end": "2969370"
  },
  {
    "text": "meta-learning strategies is the following: we assume that we have a- meta- we train a meta-learning model over a variety of",
    "start": "2969370",
    "end": "2975250"
  },
  {
    "text": "learning tasks and that model is optimized for- to achieve the best performance on a distribution of tasks,",
    "start": "2975250",
    "end": "2982330"
  },
  {
    "text": "including potentially unseen tasks. The way to think of meta-learning is that think of",
    "start": "2982330",
    "end": "2987565"
  },
  {
    "text": "each learning task being defined and associated with the small dataset, D, that contains both data instances,",
    "start": "2987565",
    "end": "2994960"
  },
  {
    "text": "feature vectors, and some true labels. And so meta-learning is then, uh, concerned with ide- um,",
    "start": "2994960",
    "end": "3001980"
  },
  {
    "text": "finding the optimal parameters Theta star for the model, uh, that would minimize the loss function across those,",
    "start": "3001980",
    "end": "3011160"
  },
  {
    "text": "uh, large number of datasets, each describing a different task. So if those models can define success with those parameters,",
    "start": "3011160",
    "end": "3019470"
  },
  {
    "text": "Theta star can define successfully, that indicates that the model was able to really successfully generalize from one task to the other,",
    "start": "3019470",
    "end": "3028005"
  },
  {
    "text": "from one dataset to the other, and so if can- if it can do that effectively to the process known as Meta training,",
    "start": "3028005",
    "end": "3034695"
  },
  {
    "text": "then we can hope that also in the case of at task time, it will be able to very quickly,",
    "start": "3034695",
    "end": "3040619"
  },
  {
    "text": "very effectively adapt to a new task, in our case, that will be a new disease, COVID-19.",
    "start": "3040620",
    "end": "3046995"
  },
  {
    "text": "So this looks very similar to just normal, regular machine learning task, but you can think this actually one data sample",
    "start": "3046995",
    "end": "3054119"
  },
  {
    "text": "is not a single note, it's not a single, uh, uh, edge in the graph but essentially, a data sample is- is small dataset,",
    "start": "3054120",
    "end": "3061230"
  },
  {
    "text": "which in our case would be a small part of the graph on which the model is straight.",
    "start": "3061230",
    "end": "3066240"
  },
  {
    "text": "So, as- uh, uh, uh, a second slide of the background of meta-learning is- is about few-shot learning,",
    "start": "3066240",
    "end": "3071820"
  },
  {
    "start": "3067000",
    "end": "3175000"
  },
  {
    "text": "which is just a specific instantiation of meta-learning in the field of supervised learning and I mentioned in there just because I want to introduce a no-",
    "start": "3071820",
    "end": "3079065"
  },
  {
    "text": "s- a one notation and that notation is, uh, uh, describes the difficulty of a few- a few-shot learning tasks,",
    "start": "3079065",
    "end": "3087485"
  },
  {
    "text": "where we will say that we are interested in solving a k-shot n-class-",
    "start": "3087485",
    "end": "3092755"
  },
  {
    "text": "classification problem the- which meaning that we want to solve a task for that,",
    "start": "3092755",
    "end": "3098625"
  },
  {
    "text": "uh, in a problem for which we only have k labeled examples for each of n classes.",
    "start": "3098625",
    "end": "3104250"
  },
  {
    "text": "So what is showing here in this slide is an example of a two-shot three-way image classification where we would have- uh,",
    "start": "3104250",
    "end": "3111164"
  },
  {
    "text": "where each task would consist of classifying im- class- uh, images into three classes.",
    "start": "3111165",
    "end": "3117524"
  },
  {
    "text": "That's why it's two-way image classification and for each class, we have two examples. And so the process here would be the during training thought- phase we",
    "start": "3117524",
    "end": "3124950"
  },
  {
    "text": "def- we sample and define a large number of training tasks, each of them is an instance of two-shot three-way image classification and",
    "start": "3124950",
    "end": "3132870"
  },
  {
    "text": "so if the model can be successfully primed to- to solve these, uh, to, uh, or to- to solve this task during meta-training phase then in,",
    "start": "3132870",
    "end": "3141930"
  },
  {
    "text": "during Meta testing time, then, uh, the model would- would quickly adapt to",
    "start": "3141930",
    "end": "3147465"
  },
  {
    "text": "completely new set of classes for which only a handful of labels are given as well.",
    "start": "3147465",
    "end": "3152595"
  },
  {
    "text": "The goal that we will have here now that we have this background on few-shot or making meta-learning is how to- how to make predictions,",
    "start": "3152595",
    "end": "3161190"
  },
  {
    "text": "uh, on a new graph or a new label set. So essentially, we want to use few-shot learning,",
    "start": "3161190",
    "end": "3166830"
  },
  {
    "text": "not on- for image classification- we want- but we want to use it- use it for graphs. Okay?",
    "start": "3166830",
    "end": "3173740"
  },
  {
    "text": "Um, so the problem formulation, um, is- of this problem is the following, uh, and,",
    "start": "3173740",
    "end": "3180119"
  },
  {
    "start": "3175000",
    "end": "3217000"
  },
  {
    "text": "um, we are interested in designing a meta-learner. Uh, that meta-learner will be concerned with, um,",
    "start": "3180120",
    "end": "3187050"
  },
  {
    "text": "will need to be able to classify an unseen label set, so that could be lab- a blue label set,",
    "start": "3187050",
    "end": "3193140"
  },
  {
    "text": "by observing some other label sets in the same graph. So during, um, training, uh,",
    "start": "3193140",
    "end": "3199590"
  },
  {
    "text": "the model will be lear- only on yellow labels and we would expect that the model would be- would be able to generalize to blu- blue labels that are defined within the same graph,",
    "start": "3199590",
    "end": "3209684"
  },
  {
    "text": "um, during, uh, test time. And so the meta that does that is called,",
    "start": "3209685",
    "end": "3214785"
  },
  {
    "text": "um, is- is called the G-Meta. The overview of G-Meta, if I present it in similar way as I have done for few- few-shot learning, uh,",
    "start": "3214785",
    "end": "3222570"
  },
  {
    "start": "3217000",
    "end": "3311000"
  },
  {
    "text": "just a few slides ago, it's very similar to the general few-shot learning setting, but now we are not concerned with, um,",
    "start": "3222570",
    "end": "3229170"
  },
  {
    "text": "solving image classification task but we are concerned with solving graph, um, um, um, learning problems.",
    "start": "3229170",
    "end": "3237255"
  },
  {
    "text": "Um, in- in- for the case of this, uh, explanation those would be node classification problems. But during training time,",
    "start": "3237255",
    "end": "3243674"
  },
  {
    "text": "we would define a large number of- of tasks, each, um, from a different- from a particular label set and at task time,",
    "start": "3243675",
    "end": "3251519"
  },
  {
    "text": "the new task will be presented on label set 3 that would not be seen, that was not present at training time.",
    "start": "3251519",
    "end": "3258090"
  },
  {
    "text": "So the key idea that G-Meta uses to solve these, uh, to solve the few-shot learning problem on- on graphs is that it was specified,",
    "start": "3258090",
    "end": "3268305"
  },
  {
    "text": "uh, um, you know, a signature function for each learning task.",
    "start": "3268305",
    "end": "3273510"
  },
  {
    "text": "That signature function will be, uh, defined based on the structure of- of,",
    "start": "3273510",
    "end": "3278789"
  },
  {
    "text": "um, subgraphs that encompass, uh, labeled examples in each task and then",
    "start": "3278790",
    "end": "3285750"
  },
  {
    "text": "those subgraphs signature functions will essentially lear- uh, that, uh, will learn how to map the structure of sampled subgraphs",
    "start": "3285750",
    "end": "3292650"
  },
  {
    "text": "representing tasks and how- and effectively, uh, serve, uh, sen- initialization for a GNN.",
    "start": "3292650",
    "end": "3299220"
  },
  {
    "text": "And so this treated, it can be really effectively- the strategy of extracting subgraphs that enclose",
    "start": "3299220",
    "end": "3304560"
  },
  {
    "text": "labeled example and then applying GNN to each subgraph individually is effective strategy for doing- for doing few-shot learning.",
    "start": "3304560",
    "end": "3312390"
  },
  {
    "start": "3311000",
    "end": "3394000"
  },
  {
    "text": "A natural question to ask now is just conceptually, which is an interesting question, what is the value of these local subgraphs that we are using",
    "start": "3312390",
    "end": "3320099"
  },
  {
    "text": "now to transfer knowledge from one task to the other? And the reasoning for why subgraphs, um,",
    "start": "3320100",
    "end": "3325349"
  },
  {
    "text": "um, are useful here is the following. You can think of, there are two fundamental core sources of information that the GNNs are using.",
    "start": "3325350",
    "end": "3334525"
  },
  {
    "text": "One is based that on label propagation, where we can think of nodes that have the same label,",
    "start": "3334525",
    "end": "3340925"
  },
  {
    "text": "they tend to be nearby in the graphs. We have seen at the beginning of the lecture today that proteins that tend to",
    "start": "3340925",
    "end": "3346415"
  },
  {
    "text": "interact the- they are also tend to lit- uh, be, uh, affiliated with similar phenotypes in similar diseases.",
    "start": "3346415",
    "end": "3355275"
  },
  {
    "text": "The other core source of GNN power is structural similarity, where nodes that have the same label,",
    "start": "3355275",
    "end": "3361590"
  },
  {
    "text": "they might not be nearby in the graph but they might have similar network shapes in their local neighborhoods.",
    "start": "3361590",
    "end": "3366690"
  },
  {
    "text": "Okay. So now that we know that, we know that in the case of few-shot learning where labels are really",
    "start": "3366690",
    "end": "3373320"
  },
  {
    "text": "scarce that we- that we cannot rely much on label propagation. It's simply not sufficient.",
    "start": "3373320",
    "end": "3378405"
  },
  {
    "text": "It's- it's where only a handful of nodes are labeled. It's very challenging to effectively propagate labels to the entire graph.",
    "start": "3378405",
    "end": "3384780"
  },
  {
    "text": "So instead, we can much better leverage structural information and structural equivalence,",
    "start": "3384780",
    "end": "3389880"
  },
  {
    "text": "which is exactly what these local subgraphs, uh, capture as a mechanism for transferring knowledge across tasks.",
    "start": "3389880",
    "end": "3396765"
  },
  {
    "start": "3394000",
    "end": "3434000"
  },
  {
    "text": "And it is actually possible to show theoretically that local subgraphs that are a fine- defined around the,",
    "start": "3396765",
    "end": "3403170"
  },
  {
    "text": "uh, labeled examples capture much of relevant information for prediction. And beyond theoretical findings,",
    "start": "3403170",
    "end": "3411180"
  },
  {
    "text": "it has been well, um, demonstrated by many studies, ah, uh,",
    "start": "3411180",
    "end": "3417359"
  },
  {
    "text": "in the context of biological networks that typically most useful information for,",
    "start": "3417360",
    "end": "3423090"
  },
  {
    "text": "uh, that to describes a particular task, um, in the context of biological network exist in some two,",
    "start": "3423090",
    "end": "3429690"
  },
  {
    "text": "three-hop neighborhoods around target nodes, so the use of local subgraphs is then highly motivated.",
    "start": "3429690",
    "end": "3435150"
  },
  {
    "start": "3434000",
    "end": "4879000"
  },
  {
    "text": "Okay. So let's return now finally, uh, to our COVID-19 repurposing problem.",
    "start": "3435150",
    "end": "3441345"
  },
  {
    "text": "And so I- I will start with description of the dataset on which this, with the- the- the- this transfer",
    "start": "3441345",
    "end": "3449160"
  },
  {
    "text": "of this- this few-shot learning strategy that I described was applied. So the repurposing dataset had,",
    "start": "3449160",
    "end": "3455895"
  },
  {
    "text": "had three major components. The first was information on how to even represent COVID-19.",
    "start": "3455895",
    "end": "3462119"
  },
  {
    "text": "Okay. How can we represent it in the form of a graph or some structure that- that is machine-readable that we can actually compute over?",
    "start": "3462120",
    "end": "3470250"
  },
  {
    "text": "And so to do that, we relied on the study that, uh, was published in, um, last year in, uh,",
    "start": "3470250",
    "end": "3477974"
  },
  {
    "text": "in Nature by Gordon et al and colleagues from UCSF and they- what they have done, they have, uh,",
    "start": "3477975",
    "end": "3484155"
  },
  {
    "text": "expressed 26 out of 29 proteins in SARS-CoV2 virus and they have checked",
    "start": "3484155",
    "end": "3491445"
  },
  {
    "text": "what are human proteins that those viral proteins take. And so in doing so, they identified",
    "start": "3491445",
    "end": "3497535"
  },
  {
    "text": "332 human proteins to reach the SARS-CoV2 virus binds.",
    "start": "3497535",
    "end": "3503430"
  },
  {
    "text": "And so that can be used as essentially computational- co- computable representation of COVID-19.",
    "start": "3503430",
    "end": "3509730"
  },
  {
    "text": "COVID-19 can be then represented by that set or subgraph or structure of",
    "start": "3509730",
    "end": "3515130"
  },
  {
    "text": "332 human proteins that are directly affect by the virus.",
    "start": "3515130",
    "end": "3520755"
  },
  {
    "text": "So these are known as viral-human protein-protein interactions because they are actually interaction between the virus and humans.",
    "start": "3520755",
    "end": "3528405"
  },
  {
    "text": "The second important information was that on, what are other proteins that those a- pro,",
    "start": "3528405",
    "end": "3536070"
  },
  {
    "text": "uh, proteins interact with? So that is the human interactome network or the human protein-protein interaction network.",
    "start": "3536070",
    "end": "3543180"
  },
  {
    "text": "And the third piece of information was up, um, the information about, um,",
    "start": "3543180",
    "end": "3548520"
  },
  {
    "text": "existing drugs on the market. So for each and every dru- existing drug we put information on its known targets,",
    "start": "3548520",
    "end": "3555645"
  },
  {
    "text": "uh, on proteins that those drugs bind to, and that gave, um,",
    "start": "3555645",
    "end": "3561105"
  },
  {
    "text": "rise to those drug modules, which would- would be the set of proteins for each drug that",
    "start": "3561105",
    "end": "3566790"
  },
  {
    "text": "are- that are targeted when the patient takes the drug. So COVID-19 ultimately was represented as a network neighborhood of",
    "start": "3566790",
    "end": "3574980"
  },
  {
    "text": "human PPI network targeted by SARS-CoV-2 virus. And the few-shot learning strategy was then applied to learn the embedding for COVID, uh,",
    "start": "3574980",
    "end": "3586410"
  },
  {
    "text": "COVID-19 that was the new task which is that we wanted to, uh, rank drugs for based on how promising they might be for COVID-19.",
    "start": "3586410",
    "end": "3596565"
  },
  {
    "text": "The way the model was optimized, it was optimized based on known drug disease indications for",
    "start": "3596565",
    "end": "3603555"
  },
  {
    "text": "other drugs and other diseases that are much better understood than COVID-19.",
    "start": "3603555",
    "end": "3609464"
  },
  {
    "text": "So that process yield an embedding space for approved drugs and diseases.",
    "start": "3609465",
    "end": "3615225"
  },
  {
    "text": "Uh, one point in that embedding space was the point that represented COVID- 19. So an effective way to identify oppor- repurposing opportunities for",
    "start": "3615225",
    "end": "3624000"
  },
  {
    "text": "COVID-19 was to look at what are other, um, what are drugs that are embedded close to the COVID-19, this em- embedding,",
    "start": "3624000",
    "end": "3633644"
  },
  {
    "text": "and then prioritize drugs based on that closeness between,",
    "start": "3633645",
    "end": "3639405"
  },
  {
    "text": "uh, COVID-19 embedding and the drugs embedding. And that- that gives rise to a ranked list of",
    "start": "3639405",
    "end": "3645119"
  },
  {
    "text": "drugs where those are the top represents most promising algorithm- uh, most promising opportunities for repurposing in the context of COVID-19.",
    "start": "3645120",
    "end": "3653744"
  },
  {
    "text": "The first test to do when you have such a model is to try to get a bit- uh,",
    "start": "3653745",
    "end": "3660195"
  },
  {
    "text": "some understanding into how accurate those predictions are. So what this plot is showing,",
    "start": "3660195",
    "end": "3665865"
  },
  {
    "text": "it is an AUC-ROC, uh, plot, um, that, um, shows on the x-axis false positive rate,",
    "start": "3665865",
    "end": "3672015"
  },
  {
    "text": "on the y-axis true positive rate of a prediction problem, which was defined as a question of,",
    "start": "3672015",
    "end": "3679424"
  },
  {
    "text": "can- can these models effectively identify those drugs that were at, uh, in April 2020 investigated on clinical trials for COVID-19.",
    "start": "3679425",
    "end": "3688770"
  },
  {
    "text": "And so a number of baseline methods were, uh, tested for this, uh, question. Uh, the three GNN-based method- the four GNN-based methods are called,",
    "start": "3688770",
    "end": "3697815"
  },
  {
    "text": "uh, A1, uh, are denoted A1 up to A4, and they showed substantial improvement in performance relative",
    "start": "3697815",
    "end": "3704340"
  },
  {
    "text": "to some other networks medicine-based, uh, strategies based on diffusions,",
    "start": "3704340",
    "end": "3710490"
  },
  {
    "text": "random walks, network proximity, and others that are more commonly deployed in the field of drug repurposing.",
    "start": "3710490",
    "end": "3715769"
  },
  {
    "text": "Then, finding it by itself, however, while promising, it's not particularly exciting because the fact that a drug is",
    "start": "3715770",
    "end": "3724365"
  },
  {
    "text": "investigated in clinical trials for COVID-19 does not really mean that it's successful. So a real test of the accuracy and",
    "start": "3724365",
    "end": "3732270"
  },
  {
    "text": "the ability of the predictions being useful is to experimentally validate predictions. So for that, biologists and",
    "start": "3732270",
    "end": "3740910"
  },
  {
    "text": "virologists from the National Emerging Infectious Disease Laboratory, so this is a national laboratory that can work with live viruses and it looks like this.",
    "start": "3740910",
    "end": "3749790"
  },
  {
    "text": "So it's looks like very kind of almost like some kind of environment in a space where nobody can enter except those with very particular access.",
    "start": "3749790",
    "end": "3759500"
  },
  {
    "text": "And they're able to work with live viruses there. So virologists there took the top predictions made by the model,",
    "start": "3759500",
    "end": "3768990"
  },
  {
    "text": "and then test- screen those predictions for their efficacy in first African monkey cells,",
    "start": "3768990",
    "end": "3775350"
  },
  {
    "text": "which are VeroE6 cells, a very prominent cell line for COVID-19 tests and later in mouse in human cells.",
    "start": "3775350",
    "end": "3782625"
  },
  {
    "text": "So the result of that was that, uh, 77 drugs that were predicted showed",
    "start": "3782625",
    "end": "3787890"
  },
  {
    "text": "strong or weak effect and they were active over a broad range of concentrations. Importantly, those predictions that were",
    "start": "3787890",
    "end": "3795510"
  },
  {
    "text": "obtained by GNN and actually an assemble of methods, including some of the other network medicine methods,",
    "start": "3795510",
    "end": "3801690"
  },
  {
    "text": "gave an order of magnitude higher hit rate among top predictions than prior work.",
    "start": "3801690",
    "end": "3808380"
  },
  {
    "text": "So prior work would be just brute force tests of all drugs in,",
    "start": "3808380",
    "end": "3813450"
  },
  {
    "text": "uh, in, uh, in a- in the lab. And if that is not done in a brute force manner,",
    "start": "3813450",
    "end": "3820050"
  },
  {
    "text": "but it's rather informed by prioritized list of drugs produced by ML models,",
    "start": "3820050",
    "end": "3827430"
  },
  {
    "text": "then an order of magnitude, uh, better hit rate is something that we could expect.",
    "start": "3827430",
    "end": "3833775"
  },
  {
    "text": "Since we are in the, um, in a course which is concerned about networks, there is an interesting finding that I want to mention here.",
    "start": "3833775",
    "end": "3841425"
  },
  {
    "text": "Um, so a natural question to ask is great. So this analysis identified 77 drugs.",
    "start": "3841425",
    "end": "3847920"
  },
  {
    "text": "Is there something common to those drugs that inhibited viral growth?",
    "start": "3847920",
    "end": "3853109"
  },
  {
    "text": "So the answer to that question is yes. So 76 out of 77 drugs that were predicted",
    "start": "3853110",
    "end": "3859589"
  },
  {
    "text": "and experimentally showed that they successfully reduced viral infection, were though kind of drugs that do not directly bind",
    "start": "3859590",
    "end": "3867180"
  },
  {
    "text": "to those human proteins that the virus directly attacks. Instead, those drugs rely on network-based action.",
    "start": "3867180",
    "end": "3875579"
  },
  {
    "text": "Those drugs, such as D3 here, would target some human proteins that are not directly attacked by the virus.",
    "start": "3875580",
    "end": "3884130"
  },
  {
    "text": "And those human proteins in turn would interact with some other proteins who in turn, finally, would be exactly those proteins that the virus attacks.",
    "start": "3884130",
    "end": "3892560"
  },
  {
    "text": "Why- why am I mentioning that? It's because these kinds of drugs,",
    "start": "3892560",
    "end": "3897990"
  },
  {
    "text": "which we now call network drugs are- could not be identified by traditional strategies for drug purposing,",
    "start": "3897990",
    "end": "3904935"
  },
  {
    "text": "which in computational biology and computational pharmacology are based on docking.",
    "start": "3904935",
    "end": "3910080"
  },
  {
    "text": "Okay, so since I'm already running over time, I will wrap up here.",
    "start": "3910080",
    "end": "3916740"
  },
  {
    "text": "So to summarize the lecture, um, today, uh, we talked about interesting applications of",
    "start": "3916740",
    "end": "3923550"
  },
  {
    "text": "graph neural networks in computational biology and we touched two top- three topics. We talked about using GNNs for modelings in",
    "start": "3923550",
    "end": "3932505"
  },
  {
    "text": "drug combinations and identifying adverse events and concerns regarding safety of drugs.",
    "start": "3932505",
    "end": "3938384"
  },
  {
    "text": "We then talked about opportunities for- that GNNs present for, uh, finding diagnostic tests and classifying diseases.",
    "start": "3938385",
    "end": "3946740"
  },
  {
    "text": "And finally, we talked about ways of- for using GNNs to identify, uh,",
    "start": "3946740",
    "end": "3952335"
  },
  {
    "text": "promising therapeutic opportunities with a particular angle, which was that of opportunities for never before seen emerging diseases.",
    "start": "3952335",
    "end": "3960869"
  },
  {
    "text": "So, uh, this concludes my last lecture here, I'm very happy to take questions. Thank you.",
    "start": "3960870",
    "end": "3967740"
  },
  {
    "text": "Uh, thank you very much Marinka, uh, this was awesome. Um, would you want to comment a bit more about what do you think are, uh,",
    "start": "3967740",
    "end": "3976710"
  },
  {
    "text": "big challenges, uh, in bio-medicine that are ready to be attacked by machine learning AI methods?",
    "start": "3976710",
    "end": "3985365"
  },
  {
    "text": "Wow, that's a very- uh, that's a very broad question.",
    "start": "3985365",
    "end": "3990480"
  },
  {
    "text": "So the way I would think of bio-medicine is, um, in the following way.",
    "start": "3990480",
    "end": "3996290"
  },
  {
    "text": "So we can broadly think about certain core problems. So one core problem is, um, related to diagnosing patients.",
    "start": "3996290",
    "end": "4004265"
  },
  {
    "text": "Before any kind of treatment can be identified or any kind of drug can be recommended,",
    "start": "4004265",
    "end": "4010190"
  },
  {
    "text": "we first need to know what are, uh, what is the disease that the patient has. So a core challenging problem that is- that is ready to be",
    "start": "4010190",
    "end": "4018155"
  },
  {
    "text": "tackled from the AML standpoint here is in particularly, um, uh, we need methods for rapid diagnosis of patients.",
    "start": "4018155",
    "end": "4027020"
  },
  {
    "text": "In particular, those patients that have, uh, that are hard to diagnose and have many rare novel diseases.",
    "start": "4027020",
    "end": "4034805"
  },
  {
    "text": "You might say, well, that might not be lots of patients, but it turns out that 20% of all patients in the US have these kinds of diseases.",
    "start": "4034805",
    "end": "4043653"
  },
  {
    "text": "On average, a patient or patients we treat these rare diseases need to visit seven specialists before they are correctly diagnosed.",
    "start": "4043654",
    "end": "4052489"
  },
  {
    "text": "That's again a huge problem for healthcare systems, for individuals, etc, etc. So now the data-sets are available to expedite the diagnosis tasks considerably.",
    "start": "4052489",
    "end": "4062298"
  },
  {
    "text": "So I think that's one exciting problem in direction to pursue. Sorry, just to ask a follow up.",
    "start": "4062299",
    "end": "4068135"
  },
  {
    "text": "So do you think of this as a active learning type problem where you also recommend what other tests,",
    "start": "4068135",
    "end": "4074240"
  },
  {
    "text": "uh, to take so that you can diagnose the disease?",
    "start": "4074240",
    "end": "4078360"
  },
  {
    "text": "Probably not. Because, uh, the problem is that if you think of- if you look at those patients,",
    "start": "4079540",
    "end": "4088220"
  },
  {
    "text": "they already went to many, many tests. So they more or less, they took lots of different tests and we",
    "start": "4088220",
    "end": "4093650"
  },
  {
    "text": "don't know what- what else to do. So it's not that much a question of identifying what lab tests should they conduct,",
    "start": "4093650",
    "end": "4101825"
  },
  {
    "text": "but the problem is that you- we can ask ourselves why we cannot diagnose patients easily.",
    "start": "4101825",
    "end": "4106955"
  },
  {
    "text": "The problem is that they are- they are conflicting in some way, meaning that a patient would come and would present- presents with",
    "start": "4106955",
    "end": "4115969"
  },
  {
    "text": "phenotypes in symptoms that don't match with any known disease classification, right?",
    "start": "4115970",
    "end": "4121279"
  },
  {
    "text": "So the way patient comes to the physician, the physician has a huge book then they- they- they- they- open and they say,",
    "start": "4121280",
    "end": "4126859"
  },
  {
    "text": "\"Okay, this is a- these are the symptoms that I would expect for disease A.\" And they compare that with patients in terms, there's no match.",
    "start": "4126860",
    "end": "4133460"
  },
  {
    "text": "Okay, so no disease A, let's go to disease B, let's go to disease C. And the problem that it's hard to diagnose patients is that they",
    "start": "4133460",
    "end": "4140599"
  },
  {
    "text": "somehow have a mixture of symptoms that don't align well with any of the disease.",
    "start": "4140600",
    "end": "4145775"
  },
  {
    "text": "So it's- it's really more about essentially diagnosing them and the question is, what is a good diagnosis?",
    "start": "4145775",
    "end": "4151880"
  },
  {
    "text": "Probably, it's not just saying a patient has disease A, but it has these- these set of diseases which",
    "start": "4151880",
    "end": "4158795"
  },
  {
    "text": "or can be learned so kind of distribution over known diseases that capture the patient well.",
    "start": "4158795",
    "end": "4164390"
  },
  {
    "text": "Uh-huh. It's just the first task of identifying what's- what's wrong with- with the individual, right?",
    "start": "4164390",
    "end": "4171170"
  },
  {
    "text": "Immediate next question is, can we identify successful treatments? So here, all the questions related to drug discovery and",
    "start": "4171170",
    "end": "4178880"
  },
  {
    "text": "development apply in the sense of can we re-purpose existing drugs? Can we identify combinations of drugs that might work for a patient?",
    "start": "4178880",
    "end": "4187310"
  },
  {
    "text": "Can we do that in a more personalized way? And it's possible now to date, meaning that the data-sets are ready and available to move away from the one size fits",
    "start": "4187310",
    "end": "4197614"
  },
  {
    "text": "all treatment recommendation which is still more or less the kind of work that I've been describing in the lecture today.",
    "start": "4197615",
    "end": "4204530"
  },
  {
    "text": "It's essentially one size fits all treatment recommendation. But it's now possible to go to a more precise level,",
    "start": "4204530",
    "end": "4211040"
  },
  {
    "text": "at least at the stage of patient groups. Meaning what would work for certain genders, certain ages,",
    "start": "4211040",
    "end": "4216395"
  },
  {
    "text": "certain combinations of gender, age, or molecular markers. Um, I think then- there is another large group of",
    "start": "4216395",
    "end": "4225364"
  },
  {
    "text": "very important high impactful question in biomedicine to ask, which are related to, um, uh,",
    "start": "4225365",
    "end": "4233270"
  },
  {
    "text": "temporal aspects of how diseases progress and how to monitor the, uh, patients and help them improve their, uh, self-care.",
    "start": "4233270",
    "end": "4241235"
  },
  {
    "text": "So that- that's- those are important questions to- to tackle for which datasets are available as well.",
    "start": "4241235",
    "end": "4247565"
  },
  {
    "text": "And then close collaborations with health care systems would offer lots of opportunities for kind of, um, tedious work.",
    "start": "4247565",
    "end": "4256909"
  },
  {
    "text": "[LAUGHTER] Tedious work would be optimizing clinical, uh, workflows, identifying medical errors.",
    "start": "4256910",
    "end": "4261995"
  },
  {
    "text": "In, um, uh, then proposing systems that have,",
    "start": "4261995",
    "end": "4267020"
  },
  {
    "text": "at the end that use active learning to then identify, uh,",
    "start": "4267020",
    "end": "4272150"
  },
  {
    "text": "what- when to- um, uh, [NOISE] when to add another drug to patients,",
    "start": "4272150",
    "end": "4277670"
  },
  {
    "text": "remove a drug from the patient, when to call the patient to come to the- to the clinic.",
    "start": "4277670",
    "end": "4283205"
  },
  {
    "text": "Um, so those are all exciting questions and some new questions have emerged during the pandemic.",
    "start": "4283205",
    "end": "4288304"
  },
  {
    "text": "And type- an example of a question that is new is that of,",
    "start": "4288305",
    "end": "4293480"
  },
  {
    "text": "um, [NOISE] uh, remote medical visits. Um, that is particularly very exciting topic nowadays in the interface of,",
    "start": "4293480",
    "end": "4302675"
  },
  {
    "text": "uh, AI in medical space. In particular, the question is, can we design various AI systems that could help, um, uh,",
    "start": "4302675",
    "end": "4314135"
  },
  {
    "text": "doctors to perform visits remotely in the sense that,",
    "start": "4314135",
    "end": "4319474"
  },
  {
    "text": "um, one would have, uh, uh, uh, it would be possible to take an image with, uh,",
    "start": "4319475",
    "end": "4324800"
  },
  {
    "text": "the- the- of- um, a patient would take, um, an image with- with their app, and that image would be analyzed automatically, um,",
    "start": "4324800",
    "end": "4331715"
  },
  {
    "text": "on the patient side and then communicated to the physician. Or and- and here in particular,",
    "start": "4331715",
    "end": "4336739"
  },
  {
    "text": "active learning strategy is- is most important to ex- for example, identify what part of the data is most crucial to have in order to make diagnosis, right?",
    "start": "4336740",
    "end": "4348080"
  },
  {
    "text": "And then can that part of the data being acquired without the patient necessarily visiting with [NOISE] hospital?",
    "start": "4348080",
    "end": "4354695"
  },
  {
    "text": "And [OVERLAPPING] that would- that would enable, um, uh, remote diagno- diagnosis and management.",
    "start": "4354695",
    "end": "4361790"
  },
  {
    "text": "Uh, this is super cool. So, uh, I guess a follow-up, uh, question, uh, is, uh, especially for the first few,",
    "start": "4361790",
    "end": "4369020"
  },
  {
    "text": "uh, problems that you are mentioning. Why are graphs essentials? Like- like, uh, why are these,",
    "start": "4369020",
    "end": "4374239"
  },
  {
    "text": "uh, graph problems and, you know, not natural language problems or, uh, you know, computer vision problems?",
    "start": "4374240",
    "end": "4380465"
  },
  {
    "text": "Why do you think graphs are essential in this case? That's a great question. I tried to shed some light into this question at",
    "start": "4380465",
    "end": "4386860"
  },
  {
    "text": "the very beginning of the talk- of the very beginning of this lecture. And, um, so the- the answer to your question would",
    "start": "4386860",
    "end": "4394480"
  },
  {
    "text": "have- would have- would have be- would have two- two parts. The first part is that it's very easy to see that,",
    "start": "4394480",
    "end": "4403295"
  },
  {
    "text": "um, most of the problems in biology are co-dependent,",
    "start": "4403295",
    "end": "4408440"
  },
  {
    "text": "or in- in the sense of whatever task we pick up, typically,",
    "start": "4408440",
    "end": "4413494"
  },
  {
    "text": "there- there are substantial relationships between important entities in that task that need to be modeled and decades",
    "start": "4413494",
    "end": "4421175"
  },
  {
    "text": "of kind of fundamental biological research has shown that those dependencies are really important and cannot be ignored.",
    "start": "4421175",
    "end": "4428840"
  },
  {
    "text": "So the relational structure of the dataset is very universal. So we have seen that for essentially all three problems discussed in this talk,",
    "start": "4428840",
    "end": "4436640"
  },
  {
    "text": "that that's indeed the case and it has been shown over and over again experimentally from protein interaction network,",
    "start": "4436640",
    "end": "4443540"
  },
  {
    "text": "CRISPR gene editing, disease diagnosis tasks, and so on. So- so these are relations are an important component of the dataset.",
    "start": "4443540",
    "end": "4450500"
  },
  {
    "text": "So we would need to leverage models for for those tasks. Second is, not only that, um,",
    "start": "4450500",
    "end": "4456215"
  },
  {
    "text": "these relations exist, but they are, in most cases really informative, sometimes even more informative than- than structural data,",
    "start": "4456215",
    "end": "4465155"
  },
  {
    "text": "for example, for the problems of predicting, uh, proteins, uh, structure.",
    "start": "4465155",
    "end": "4470420"
  },
  {
    "text": "The recent models put out by DeepMind actually leverage relational, uh, information about proteins to infer what their structure is, uh, about.",
    "start": "4470420",
    "end": "4480785"
  },
  {
    "text": "And- and- and so not only the datasets, uh, and problems are- have strong relational structure,",
    "start": "4480785",
    "end": "4487325"
  },
  {
    "text": "but that relational structure correlates well with predictive tasks that we want to produce.",
    "start": "4487325",
    "end": "4492995"
  },
  {
    "text": "And so then some form of graph-based machine learning, um, seems very suitable.",
    "start": "4492995",
    "end": "4499775"
  },
  {
    "text": "Uh, thank you- thank you so much. Uh, one more, uh, question, um, is about, uh,",
    "start": "4499775",
    "end": "4507245"
  },
  {
    "text": "how effective has been to get the medical community to adapt to these methods?",
    "start": "4507245",
    "end": "4512720"
  },
  {
    "text": "Um, and, uh, uh, yeah, so that I guess is, uh, the question. So that's a great question and",
    "start": "4512720",
    "end": "4519440"
  },
  {
    "text": "the short answer to that is would be it's- it's challenging. [LAUGHTER] So first to ans- to answer that,",
    "start": "4519440",
    "end": "4526175"
  },
  {
    "text": "by now we have seen several examples of successful deployments of, um, this algor- um,",
    "start": "4526175",
    "end": "4533195"
  },
  {
    "text": "ML algorithms in general, in clinical settings as well as in large pharma companies. So that is primarily true,",
    "start": "4533195",
    "end": "4539885"
  },
  {
    "text": "so far, for image-based models. Um, there aren't many or I'm not aware of really successful graph-based machine model,",
    "start": "4539885",
    "end": "4549725"
  },
  {
    "text": "that is applied and used routinely in clinical contexts, or in, um, at least in public clinical settings.",
    "start": "4549725",
    "end": "4557630"
  },
  {
    "text": "What- where- where we are currently at this stage is that typically individual researchers engage with collaborators would",
    "start": "4557630",
    "end": "4564920"
  },
  {
    "text": "be physicians or clinical researchers and so on and they would work hand in hand on their particular problems and one could think of that as",
    "start": "4564920",
    "end": "4572840"
  },
  {
    "text": "validations- experimental validation of predictions but currently, we are not there yet where these methods would be routinely used,",
    "start": "4572840",
    "end": "4580025"
  },
  {
    "text": "where graph neural networks or graph ML would be routinely used in, um, in real-world.",
    "start": "4580025",
    "end": "4585155"
  },
  {
    "text": "Why is that the case? So I would argue that the main gap that is significant that exists between say,",
    "start": "4585155",
    "end": "4592730"
  },
  {
    "text": "models publishing Europe's papers, and then these models being deployed in real-world,",
    "start": "4592730",
    "end": "4597874"
  },
  {
    "text": "is this lag debt. Typically, on- when we apply these models to datasets,",
    "start": "4597874",
    "end": "4604158"
  },
  {
    "text": "they don't generate predictions that users would think of as actionable predictions. What that means is that,",
    "start": "4604159",
    "end": "4610670"
  },
  {
    "text": "it's not enough to simply predict whether a drug will treat a disease.",
    "start": "4610670",
    "end": "4615844"
  },
  {
    "text": "It's very hard to convince somebody that will follow up with very expensive downstream experiments in the lab",
    "start": "4615845",
    "end": "4621530"
  },
  {
    "text": "by this high level pointwise based prediction. So what- what I didn't discuss in the context of COVID repurposing project,",
    "start": "4621530",
    "end": "4629510"
  },
  {
    "text": "it was extraordinarily important to essentially provide explanations, allow users to provide feedback to the model,",
    "start": "4629510",
    "end": "4635870"
  },
  {
    "text": "and essentially build some trust and confidence in the model and so that has now given rise to this- some relative term of trustworthy machine learning,",
    "start": "4635870",
    "end": "4643805"
  },
  {
    "text": "which I think has- has some bearing in the context of, uh, um, biomedical applications.",
    "start": "4643805",
    "end": "4650015"
  },
  {
    "text": "Uh, thank you. Uh, then, uh, uh, two more quick questions. Uh, could you elaborate on the node feature engineering for drug- drug interaction,",
    "start": "4650015",
    "end": "4659494"
  },
  {
    "text": "uh, the drug combination in the first, uh, part of your talk? Um, and then we have one more.",
    "start": "4659495",
    "end": "4665315"
  },
  {
    "text": "Yes. So, uh, for node features in the first part of the talk, we had node features for drugs and for proteins.",
    "start": "4665315",
    "end": "4672260"
  },
  {
    "text": "Node features for drugs were, uh, SMILES fingerprints of, um, the drugs and, um,",
    "start": "4672260",
    "end": "4679895"
  },
  {
    "text": "they were- there were not manually engineered by- by us, but this is a very common descriptor of drug structure that is used in cheminformatics.",
    "start": "4679895",
    "end": "4687530"
  },
  {
    "text": "It was retrieved from a database called DrugBank. Uh, for protein nodes, the node features were",
    "start": "4687530",
    "end": "4695900"
  },
  {
    "text": "binary vectors that contained information about what molecular pathways those proteins are involved in.",
    "start": "4695900",
    "end": "4703715"
  },
  {
    "text": "For example, if we know that a protein A is- uh, participates in a cell apoptosis pathway,",
    "start": "4703715",
    "end": "4710975"
  },
  {
    "text": "this is a pathway that's incredibly important because it basically tells us- it- it has a control over when a cell should die or stay alive, right?",
    "start": "4710975",
    "end": "4719015"
  },
  {
    "text": "So if a protein is a member of that pathway, then there would be a- a simple indicator one at that,",
    "start": "4719015",
    "end": "4725300"
  },
  {
    "text": "uh, in particular- in the relevant dimension of the protein feature vector. All right, thank you. And then,",
    "start": "4725300",
    "end": "4732035"
  },
  {
    "text": "uh, uh, one, uh, I'll, uh, next question is about, uh, the G-Meta learning, how, uh, uh, somebody is interested,",
    "start": "4732035",
    "end": "4739250"
  },
  {
    "text": "how does it differ from Bayesian network learning and the EM algorithms? Could you discuss pros and cons?",
    "start": "4739250",
    "end": "4745415"
  },
  {
    "text": "Oh, I see. Interesting. So we actually didn't consider any Bayesian network learning method for the problem of- uh, of G-Meta.",
    "start": "4745415",
    "end": "4753680"
  },
  {
    "text": "We compared it primarily with, uh, current work on- um, that is graph neural network-based for few-shot learning.",
    "start": "4753680",
    "end": "4761074"
  },
  {
    "text": "I- I can clearly see from this question that it might be interesting to use, um, some Bayesian model and then learn a distribution of drug effectiveness across diseases,",
    "start": "4761075",
    "end": "4772340"
  },
  {
    "text": "and then use that to sample a new disease that would approximate COVID-19.",
    "start": "4772340",
    "end": "4777830"
  },
  {
    "text": "Um, the pros of that would be that using the Bayesian models would perhaps,",
    "start": "4777830",
    "end": "4784490"
  },
  {
    "text": "uh, give us a better ranking of drugs. Because ranking of drugs for that problem was determined on",
    "start": "4784490",
    "end": "4789920"
  },
  {
    "text": "predicted scores returned by GNNs, and we know- uh, and returned by G-Meta in particular.",
    "start": "4789920",
    "end": "4795620"
  },
  {
    "text": "Uh, from several applications, we know that often the scores that are returned by the model are not necessarily well calibrated or indicative of probabilities.",
    "start": "4795620",
    "end": "4804079"
  },
  {
    "text": "So I could imagine that the Bayesian network model might work better for that. So that would be the pros.",
    "start": "4804080",
    "end": "4809720"
  },
  {
    "text": "The cons of that, uh, would be that, um, what he found in the context of,",
    "start": "4809720",
    "end": "4815599"
  },
  {
    "text": "uh, COVID repurposing is that, uh, the G-Meta or graph neural network-based models when implemented with very recent,",
    "start": "4815600",
    "end": "4823760"
  },
  {
    "text": "um, neighborhood sampling strategies from like Cluster-GCN, or GraphSAGE for example, in other,",
    "start": "4823760",
    "end": "4829670"
  },
  {
    "text": "they can scale very well to very large datasets, um, including, for example, one dataset where we looked at, um,",
    "start": "4829670",
    "end": "4836690"
  },
  {
    "text": "information not only for humans, but from- from our 1,800 other [NOISE] species, and try to translate information from other species and model organisms like zebra,",
    "start": "4836690",
    "end": "4846490"
  },
  {
    "text": "fish, and monkeys to human. And I- um, at least in my experience, in- GNN models scale better to a larger dataset, than some Bayesian models.",
    "start": "4846490",
    "end": "4855614"
  },
  {
    "text": "Thank you so much, uh, [NOISE] Marinka for, uh, the excellent lecture and, uh, thank you everyone for asking great questions.",
    "start": "4855615",
    "end": "4862805"
  },
  {
    "text": "Uh, appreciate it a lot. Uh, thank you so much, and, uh, uh, all the best to Boston.",
    "start": "4862805",
    "end": "4868025"
  },
  {
    "text": "Great. Thank you for inviting me. Yeah, thank you. Bye bye. Bye. Bye.",
    "start": "4868025",
    "end": "4874320"
  }
]